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DEALING WITH INTERNATIONAL AIDS: A
CASE STUDY IN THE CHALLENGES OF
GLOBALIZATION
INTRODUCTION

On January 2, 2002, through January 6, 2002, the Association
of American Law Schools held its Annual Meeting in New Orleans,
Louisiana. The Gay and Lesbian Legal Issues Section and the
International Law Section conducted a joint program wherein
speeches were given addressing a single topic: "Dealing With
International AIDS: A Case Study in the Challenges of
Globalization." The following articles are adaptations of the
speeches that were given in the joint program.

RECURRING NIGHTMARE: BARRIERS TO
EFFECTIVE TREATMENT OF HIV IN THE
UNITED STATES AND INTERNATIONALLY
JOHN G. CULHANE*

This ten-minute presentation cannot cover my subject
adequately. I am going to try to hit a few of the high points. The
outline I have distributed expands on these remarks, and is more
of a working paper for an article in progress. Anyone interested in
discussing any of these matters more fully should contact me at
my e-mail address.
As the first presenter, I think there is one thing that I must
say at the outset: according to the latest estimates, forty million
people in the world today are living with HIV and AIDS.' That
doesn't need any elaboration. I just wanted to start there to
establish a context for the magnitude of the problem with which
we're dealing. What I want to do in the short time I have is to
Visiting Professor of Law, California Western School of Law
(Spring,
2002); Professor, Widener University School of Law; Lecturer, Yale University

School of Public Health.
1. UNITED NATIONS PROGRAMME ON HIV/AIDS [UNAIDS] & WHO, AIDS
EPIDEMIC UPDATE, at 1, UNAIDS Doc. UNAIDS/01.74E, W.H.O. Doc.
WHO/CDS/NCS/2001.2 (Dec. 2001) [hereinafter AIDS EPIDEMIC UPDATE].
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identify obstacles to successful prevention and treatment of HIV in
the United States and explore parallels to other countries: What
about our own successes and failures in treating the most
marginalized groups is capable of being applied to other countries?
In other words, are other countries making the same mistakes
that we are making? And then I want to finish on a somewhat
more optimistic note by talking about a range of ways to overcome
obstacles to prevention and treatment. So, first, I want to talk
about the obstacles.
The first of the obstacles is well known to women. And, in
fact, it is important to look at particular countries. If you look at
the developed world-by that I mean Western Europe and the
United States-you will find that the infection rate among women
is reasonably low. If you look at the developing and undeveloped
countries, you will find just the opposite. In fact, in sub-Saharan
Africa, fifty-five percent of those infected are women.' In the
United States though, it is important not just to look at women
generally, but to take a look at a more specific population, namely
African American women who now account for about two-thirds of
all new female HIV infections.' Why is this? I will talk about this
in some depth in a moment when I talk about a different obstacle,
but for now, we can note that this high percentage is closely
related to questions of poverty, lack of healthcare and problems in
terms of education.
Now look at another country that we typically regard as kind
of a success story in the fight against HIV/AIDS, and that is
Brazil. There, it turns out that the percent of increase in HIV and
AIDS cases of women is seventy-five percent. Among men, it is
only ten percent.4 Why is that? The problem is complex, but the
reasons have to do with the culture of machismo, which make it
difficult for women to negotiate about condom use, and with
women's lack of education about how to protect themselves.5 So
you've got a problem in the United States, which you can see is
mirrored in another country that has had some success in fighting
2. Id.; UNAIDS, REGIONAL HIV/AIDS STATISTICS AND FEATURES, END OF

2001,

UNAIDS

Doc.

No.

00002-E-2

(Dec.

2001),

available

at

http://www.unaids.org/worldaidsday/2001/EPIgraphics200l/EPIgraphic2-en.gi
f (last visited Mar. 20, 2002).
3. See Ann Carns, Twenty Years of AIDS in America: Blacks Now Account
for Half of All New HIV Infections; Homosexuality Still Taboo, WALL ST. J.,

May 30, 2001, at B1 (stating that the United States' Center for Disease
Control estimates that sixty-four percent of new HIV cases in America are
African-American women).
4. Anthony Fiola, Brazilian Women Ravaged by AIDS; Infection Rate Rises
in Culture of Denial, WASH. POST, Oct. 30, 2001, at A34.

5. See id. (stating that the Brazilian devastation is because of Brazil's
"machismo" culture and uneducated women "who often don't see themselves
with any risk factor") (quoting Paulo Roberto Teixeira, Brazil AIDS Program
secretary).
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HIV/AIDS.
Another obstacle that is even more complex, and therefore
more difficult to deal with and get around, is really a cluster of
related problems having to do with religious, cultural and
community questions or assumptions about sex, sexual behavior,
sexual orientation and condom use. I can start with something
obvious from the United States. As you know, there has been a
move toward teaching only abstinence, and calling that "sex
education." Some thirty percent of high schools are now teaching
abstinence-only education.6 This reality avoidance puts us in good
company because in Kenya, President Daniel Arap Moi, declared
So instead of
himself embarrassed to talk about condoms.
advocating condom use, he offered a "better idea": Kenyans should
abstain from sex for two years!7 Now, what kind of public policy is
that? You know, a few weeks, sure, but two years-it certainly
doesn't seem like a policy likely to be implemented. We can see
unfortunate parallels and similarities between the United States
and a place like Kenya.
There are more complex questions having to do with stigma,
sexual orientation and social hostility, and I wanted to just use
two examples here, one from the United States and one from
China. The United States case returns us to the African American
community, and here we have a toxic combination of
circumstances. You have many men who are having sex with men
but not identifying themselves as gay, for what will probably
strike you as explainable reasons if you think about them. First,
unlike white gay men, who may leave their neighborhoods and go
out and seek a community, many men who have sex with men in
the African American community stay in those communities. But
there is a lot of stigma attached to homosexuality in these
communities. Many church and religious groups do not want to
talk about it, or if they do talk about it, it is to denounce
homosexuality. So you have men having sex with men, not
acknowledging themselves as gay, spreading HIV to each other
and then spreading HIV to women with whom they are having sex.
In some cases [these are] women that they are in long term
relationships with-even married to-because it is a culture that
simply won't talk about what is going on.
Similar forces of stigma, denunciation, and denial are also at
work in China. Our information from China is not very reliable;
there is a lot we do not know. The current estimate of 600,000
infected is widely thought to be a gross underestimate. But there
6. See Sharon Lerner, An Orgy of Abstinence, VILL. VOICE, Aug. 7, 2001, at

34 (reporting the 1999 abstinence-only frequency in United States' schools at
twenty-nine percent).
7. Tom Malati, Associated Press, Kenyan President Shy to Talk About
Condoms, July 13, 2001.
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again, you have stigma concerning sexual orientation, lack of
education and local resistance.'
One other problem I want to talk about before discussing
possible solutions and approaches has to do with the close
connection between poverty, on the one hand, and poor health
outcomes, on the other. This connection has been pointed out by
many commentators, most notably the late Jonathan Mann. 9 It is
very simple if you think about it for even a second. If you are poor,
you probably have poor nutrition, less education, and less access to
healthcare.
These are all problems that you could call the
components of poverty if not its sequel. So what do we do about
that?
Well, obviously, that is a complicated issue.
Andy
mentioned that one of the things we need to -think about for
HIV/AIDS is shuffling the wealth a little bit from the richer to the
poorer. This is obviously very politically difficult to do.
Without diminishing the significance of the connection
between poverty and poor health outcomes, there is a danger we
should guard against. We should not assume that just because
people are poor and people do not have education that they are
incapable of heeding messages and incapable of taking steps to
protect themselves if we are able to go out there and make the
effort. And I want to very briefly talk about three examples that
prove the point, or at least suggest that it has some validity.
One was a study on women in New York City that was
reported in the American Journal of Public Health. These women
were at a very high risk of all kinds of sexually transmittable
diseases, including HIV. To qualify for this study, they either had
to be crack addicted, had sold sex for money, or been in prisonthose kinds of things. This was a study on vaccine efficacy to see
whether these women could be followed up on in such a trial. It
turns out ninety-two percent of those women were still showing up
for their scheduled appointments one year later." Obviously, this
is not a group that you would think easy to reach.
In Haiti, which is widely regarded, and I think rightly
regarded, as the poorest country in the Western Hemisphere, there
was a pilot program conducted to see whether it would be possible
to get Haitians to stick to HAART, Highly Active Anti-Retroviral
Therapy. It turned out that it was possible. If the subjects taking
8. Bates Gill & Sarah Palmer, The Coming AIDS Crisis in China, N.Y.
TIMES, July 16, 2001, at A15.
9. See The Body, Jonathan Mann Award for Health and Human Rights, at
http://www.thebody.com/ghc/mannaward.html (last visited Mar. 20, 2002)

(listing the Global Health Council's award criteria in remembrance of the late
epidemiologist Johnathan Mann). The web site notes that Johnathan Mann
"was able to clearly see the connection between poverty and ill health." Id.
10. Pamela Brown-Peterside et al., RetainingHard-to-Reach Women in HIV
Prevention and Vaccine Trials: Project ACHIEVE, 91 AM. J. PUB. HEALTH
1377, No.9 (Sept. 1, 2001), available at 2001 WL 11437680 (2001).
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the drugs were monitored closely enough, they followed the
regimen." And, of course, in Brazil, we know we have a poor
(although not extremely poor) country where they have been able
to drop the number of deaths due to AIDS by fifty percent over the
last few years.1' So ways of dealing with poverty can be found. We
should not let the assumption turn into a self-fulfilling prophecy
where we just say, well, there is no money there and we should
just give up. If we can target money, if we can target prevention
efforts to people, it is very possible to make a big difference.
More broadly in terms of solutions, I want to just mention a
few things very quickly. One is, of course, money again. We can
see neglect of public health at all kinds of levels. George W. Bush
went to the Center for Disease Control (CDC) and was practically
hit by falling debris because the place was falling apart. Now, an
anthrax scare is going to cause us to spend more money on public
health. But you see this is public health neglect at the local,
national and international level, where the seed fund for the
Global AIDS Fund is supposed to be seven to ten billion [dollars],
and right now, they have less than two billion [dollars]. So I think
money is the indispensable cornerstone of any successful program.
Beyond that, we need initiatives at the international level,
the national level, and the regional level and all the way down to
the local level. And I would say if access is blocked at one point,
we should seek another way of dealing with the problem. That is
why in the outline I discuss vaulting over obstacles, going around
them, sneaking under them-any way you can do it to get the
needed help to people. On the international level, I think it is well
to commend WHO and UNAIDS, who have been driving forces in
pushing HIV/AIDS onto the global "front burner." Their efforts
bore plump fruit in June, 2001, when the UN General Assembly
created a framework and got countries to commit to benchmark
targets for HIV prevention, care, support and treatment.13 This
was a very big step for the international community, and if
nothing else, it should get people to at least think about HIV on a
national level. There is another example of a multi-national
initiative from Southeast Asia that I discuss in the outline. 4
Turning to 'the national level, we again begin with the United
States. Unfortunately, any success we have had has come in spite
of a continued failure of Presidential leadership.
This is a

.11. Paul Farmer, Community-Based Approaches to HIV Treatment in
Resource-PoorSettings, 358 LANCET 404 (Aug. 4, 2001).
12. Associated Press, Brazil to Give Away 800,000 Condoms for Lovers' Day,
June 9, 2001.
13. Declaration of Commitment on HIV/AIDS, U.N. GAOR 26th Special

Sess., Annex, Agenda Item 8, U.N. Doc. A/RES/S-26/2 (2001).
14. Emma Tinkler, Associated Press, Tackling Growing Asian AIDS
Epidemic to Cost Billions, Oct. 6, 2001).
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bipartisan indictment. First, we had the Reagan administration
afraid, embarrassed, and more than a little judgmental. Reagan
and his spokespeople were simply not willing to talk about HIV at
all. It is fair to say that their silence was responsible for many
thousands of infections and deaths.
We had the Clinton
administration, which would not federally fund needle exchange
programs in spite of the good science supporting them. And now,
we have got the George W. Bush administration distancing itself
from a very good report by the Surgeon General, David Satcher, in
which he discusses the need for real sex education and for
destigmatizing gay and lesbian identity.'5
So the national
leadership in our country has not been very good.
Compare this reaction to a country like Uganda, of all places,
that has been the first country in Africa to really subdue its
HIV/AIDS epidemic. 6
The reason for that has been good
leadership at the national level, 7 willingness to talk openly about
HIV, talk about disease, talk about condom use, and they have
been extremely successful. In Cambodia, too, again there's a
willingness to talk about sex, talk about homosexuality and
condom use."
Local efforts often are about the only option you have. If you
are in a place where the national response has not been
forthcoming, I think it is very important to look for other places.
And the single best example of this is needle exchange programs
that have been blocked from funding at the national level since the
beginning of the HIV epidemic. But it turns out there are now
some eighty-one cities that are running needle exchange programs
of their own. In the year 1998, which is the most recent year for
which data have become available, almost twenty million syringes

15. See Karen S. Peterson, Satcher Urges Sex Dialogue; Critics Urge Ouster,
USA TODAY, June 29, 2001, at 1A (noting the Bush administration's concerns
with Clinton appointee Surgeon General David Satcher's self-described sex

education agenda as more "science" than politics or religion).
16. AIDS EPIDEMIC UPDATE, supra note 1, at 15.

17. Although the Ugandan leadership has generally been good, it has been
completely negative on the issue of homosexuality because the leadership
mixes both the denial and persecution of gays. See Peter O'Connor, Associated
Press, Ugandan President Honored for AIDS Fight Says Nation Has No
Homosexuals, Mar. 3, 2002 (contrasting a March 2002 speech by Ugandan

President Yoweri Museveni with Amnesty International's June 2001 report of
homosexual torture in Uganda).

In accepting an award for the nation's

successful campaign against HIV/AIDS, Ugandan President Museveni stated
that "[w]e don't have homosexuals in Uganda so this is mainly heterosexual

transmission ....Id.
18. Center for Disease Control, Malaysian Nat'l News Agency (BERNAMA),
Cambodia Takes Measures Against HIVIAIDS (Oct. 15, 2001), available at

http://www.thebody.com/cdc/newsupdates-archive/octl8_Ol/cambodia.html
(last visited Apr. 2, 2002).
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were exchanged, which was up from about eight million in 1994.19
It is a great public health success carried out at the grassroots
level.
Another encouraging example is from Baltimore. You have
the CDC, the State of Maryland and local activists all acting
toward a common purpose. They have identified areas of high risk
for HIV infection based on poverty, based on drug addiction, based
on imprisonment, and they have sent mobile vans into those areas
to deliver a package of health services. Not just HIV testing and
treatment, but an entire package of health services."0 Why is that
important? Because people feel less stigmatized that way. People
are not just going for HIV treatment and walking into this van
saying, "oh, I am identifying myself," but rather they are looking
at this as a whole package of services.
One final point is again from Kenya, now going from the
grassroots level all the way down to what the first George Bush
might have called one point of light. This is a story about a family
in Kenya that broke the taboo on talking about HIV/AIDS. When
a family member died, they put two red ribbons next to the death
announcement to show that the person had died of AIDS, and the
family said it was time to break the stigma.2 1 That is in a country
in which the president is embarrassed to talk about HIV/AIDS;
and it is a family doing this. And I think these messages of hope
can bubble up from the ground and yield good public health
outcomes. Thank you.

19. AMERICAN FOUNDATION FOR AIDS RESEARCH, NATIONAL SURVEY
SHOWS MARKED INCREASE IN SYRINGE EXCHANGE PROGRAMS: AMFAR FUNDS
SURVEY: PROGRAMS GAIN MOMENTUM AS MEANS FOR HIV PREVENTION (May

17, 2001), at http://www.amfar.org/cgi-bin/iowa/news/press.html

(last visited

Mar. 20, 2002).
20. AIDS
SITES IN

ALERT, COMMUNITY-BASED EFFORTS TO CHALK UP SUCCESSES:
NC AND MARYLAND HAVE TALE TO TELL (SUCCESS IN HIV

PREVENTION), 16, No. 12, at 160 (Dec. 1, 2001), available at 2001 WL

11585715 (listing the health screening services such as counseling and testing
for both AIDS and other health problems).
21. Matthew Green, Reuters NewMedia, Kenyan Family Shatters AIDS

Taboo

with

Death

Notice,

(July

17,

2001),

at

http://www.aegis.com/news/re/2001/RE010718.html (last visited Apr. 2, 2002).
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BIOGRAPHY OF A NIGHTMARE: HIV/AIDS
IN SOUTH AFRICA
PETER KWAN*
INTRODUCTION

"South Africa is experiencing an HIV/AIDS epidemic of
shattering dimensions."" So begins a report from South Africa's
Medical Research Council less than a year ago. It is as if the word
"epidemic" alone has lost what force it once had to convey the
enormity and tragedy of the health crisis. The fact that it is now
the "single biggest cause of death" in South Africa seems to have
lost its ability to shock. 2" HIV/AIDS in South Africa is not your
garden variety "epidemic," these scientists and actuaries (not
professions known for hyperbole) are telling us it is one of
"shattering dimensions." 4
The statistics are staggering and, after a while, mindnumbing. Reading and thinking about them is exhausting. But
that experience pales into insignificance compared with the reality
of those who have suffered and died and those who are suffering
and living with it still. There is the reality for life partners and
orphans of sufferers whose lives are shattered along with the
victims, and all those who newly fall into those categories every
day and whose numbers increase tirelessly.
The purpose of this Article is to present what is presently
known about HIV/AIDS in South Africa. This includes the most
educated and best scientific predictions of the future trends of this
disease. It provides the empirical background and helps set up the
background against which other speakers on this panel, notably
Pierre de Vos, can describe and discuss the South African
government's response to HIV/AIDS as well as recent human
rights and constitutional challenges to that government's
(in)action.25

* Peter Kwan, Visiting Professor of Law, Golden Gate University.
Heartfelt thanks to Kelly Shindell for her invaluable assistance and to Pierre
de Vos for his unfailing friendship and guidance.

22. ROB DORRINGTON ET AL., MED. RESEARCH COUNCIL OF S. AFR., THE
IMPACT OF HIV/AIDS ON ADULT MORTALITY IN SOUTH AFRICA 5 (Sept. 2001).
23. MICHELLE ROTCHFORD GALLOWAY, MED. RESEARCH COUNCIL OF S.
AFR., MRC REPORT REVEALS EXTENT OF EPIDEMIC AIDS: 'THE SINGLE

BIGGEST CAUSE OF DEATH,' 10 AIDS BULL. 3 (Dec. 2001), available at
http://www.mrc.ac.za/aids/dec200l/mrcreport.htm (last visited Apr. 19, 2002).
24. Id.
25. Pierre de Vos, HIVIAIDS in South Africa: The Good, the Bad and the
Ugly, 35 J. MARSHALL L. REV. 386 (2002).
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I.

BIRTH AND EARLY LIFE

The United States Center for Disease Control in Atlanta first
described the Acquired Immunity Disease Syndrome as a
syndrome in 1981.26 A year later, two cases were reported in South
Africa.2 7 The first death from AIDS in South Africa was reported
Although most of these first cases of
on January 20, 1989.'
infections were of white males, the profile of HIV/AIDS victims
was swiftly to change both in terms of gender and race. 29 From
1982 to 1989, the victims were disproportionately homosexual or
bisexual.3 °
The South African government's initial response to the
emerging problem was to form an AIDS Advisory Group in 1985,
whose task was both to advise and to formulate national programs
to address HIV/AIDS. It took seven years before the government
established a national AIDS program.31 In 1994, various relevant
individuals, organizations and groups created a National AIDS
Plan under the umbrella of the National Coordinating Committee
of South Africa, including local and national governments, the
African National Congress Health Secretariat, businesses and
unions.32 Under that plan, and from 1998 to 2000, the government
launched a national multi-media educational effort, the "Beyond
Awareness Campaign.""
By then, the epidemic had already
matured and was firmly entrenched among the entire South

26. United Nations Programme on HIV/AIDS, Fact Sheets: Twenty Years of
at
available
(May
2001),
AIDS
http://www.unaids.org/fact-sheets/files/AIDStwenty..en.html (last visited Apr.
19, 2002).
&
WHO,
NATIONS
PROGRAMME
ON
HIV/AIDS
27. UNITED
EPIDEMIOLOGICAL FACT SHEET ON HIV/AIDS AND SEXUALLY TRANSMITTED
INFECTION: 2000 UPDATE (REvISED) 6 (2000).

28. Four new AIDS cases were reported at the same time, one of which was
a three-month-old baby. South and Southern Africa in Brief-S. Africa AIDS
at
Jan.
23,
1989),
available
Statistics,
(BBC
broadcast,
http://www.lexis.com/research/retrieve/frames?_m=220131fcabfaff73dda0ebba
2f87850b&csvc=fr&cform=free&_fmtstr=XCITE&docnum=l &_startdoc=1 &wc
hp=dGLSzV-ISlWS&_md5=7434d808eae6ft~cd6cb873250b56c9a8 (last visited
Apr. 19, 2002).
29. In 1989, 145 of the South African AIDS victims were white, forty-one
were African, six were colored and three were Asian. From 1982 to 1989,
there were twenty cases of women with HIV/AIDS in South Africa. Id.
30. Of the 195 victims that contracted HIV/AIDS from 1982 to 1989, 129
were either homosexual or bisexual, forty-five were heterosexual, nine were
hemophiliacs, one was an intravenous drug user and seven victims were of
unknown classification. Id. These victims' overall mortality rate was fiftynine percent. Id.
31. National Coordinating Committee of South Africa, AIDS in South
Africa: Dynamics of the South African Epidemic, at http://www.aids.org.za
(last visited Apr. 19, 2002).
32. Id.
33. Id.
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African population.
II. ADULTHOOD
Securely established and without vigorous opposition in terms
of a multi-faceted and concerted social and medical response, the
epidemic has been able to wreak havoc in South Africa throughout
the 1990's and up to the present. What one knows about the
progression of HIV/AIDS through the South African population
comes mainly from survey data collected through blood test results
taken from pregnant women in public health antenatal clinics
located throughout the country.' Over eighty percent of pregnant
women in South Africa use the public antenatal care offered by the
government.35 At these clinics, pregnant women are routinely
given blood tests for syphilis. 6 Although voluntary, few women
refuse these tests 7
Each October, when testing for syphilis is administered, a test
for HIV is also done anonymously, but with the consent of the
woman.3
This is the most reliable and consistent survey data
available regarding HIV/AIDS in South Africa. There are no
surveys or direct information on infection rates among nonpregnant women, men, infants or children."
Therefore, these
figures do not present an optimum projection of the situation.
Given the sample group, the survey data tracks only heterosexual
transmission of HIV/AIDS. Even though eighty percent of all
pregnant women attend public antenatal clinics, of these, 85.2
percent are African and therefore under-presents racially.0
Nevertheless, it is international scientific practice to use pregnant
women as the sentinel population for HIV/AIDS studies and
represents the best data on the South African situation currently
available.41 In 2000, the antenatal survey included 400 public
sector clinical cites where 16,607 pregnant women were tested for
HIV.42
Notwithstanding these analytical reservations, the picture
this data shows is grim. In 1990, less than one percent of the
pregnant women being tested were HIV positive. In 2000, the rate
34. Dorrington, supra note 22, at 7.
35. Id.
36. SOUTH AFRICAN DEPT. OF HEALTH, NATIONAL HIV AND SYPHILIS SEROPREVALENCE SURVEY OF WOMEN ATTENDING PUBLIC ANTENATAL CLINICS IN
SOUTH
AFRICA:
2000,
3.6,
available
at

http://196.36.153.56/doh/docs/reports/2000/hivreport.html (last visited Apr. 19,
2002) [hereinafter DOH NATIONAL SURVEY OF WOMEN].
37. Id.

38. Id.
39. Id. 4.1.4.
40. Id. 1[3.6.
41. DOH NATIONAL SURVEY OF WOMEN, %3.4.

42. Id.
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had increased to 24.5 percent,4 3 up from 22.4 percent in 1999 and
22.8 percent in 1998." Although there was an increase in the rate
of infection in 2000, the good news is that the increase was not
exponential.45 Yet in 2000, the survey projects that South Africa
had 4.8 million people infected with HIV, "most of them being at
the prime of their age.
The South African government estimates the current
population to be 43,586,0997. 47 The mortality rate among young
adult women (between twenty-five and twenty-nine years of age)
Among men
rose 3.5 times between 1985 and 1999/2000.4
between thirty and thirty-nine years of age, the mortality rate
nearly doubled in that time period. 49 These rises in mortality rate
are consistent with actuarial predictions of deaths attributed to
AIDS.50 Notwithstanding the uncertainties regarding the data, the
Medical Research Council's report estimates that
about 40% of the adult deaths aged 15-49 that occurred in the year
2000 were due to HIV/AIDS and that about 20% of all adult deaths
in that year were due to AIDS. When this is combined with the
excess deaths in childhood, it is estimated that AIDS accounted for
about 25% of all deaths in the year 2000 and has become the single
biggest cause of death.51
By some accounts, already South Africa has the highest
number of HIV positive people of any nation,52 and AIDS related
illnesses are the "most common cause of death in the medical
wards among adults aged 19-49 at teaching hospitals affiliated to
the Universities of Cape Town, Natal and Witwatersrand."53 In
2000, the South African government's own Department of Health
estimated that 628,000, or twenty-five percent, of all public
hospital admissions were for AIDS related illnesses.'
Since HIV/AIDS predominantly affects the younger, sexually
43. Dorrington, supra note 22, at 7.
44. DOH NATIONAL SURVEY OF WOMEN,

4.1.1.

45. Id.
46. Id. 6.
47. U.S. CENT. INTELLIGENCE AGENCY, THE WORLD FACTBOOK 2001,
available at http://www.odci.gov/cia/publications/factbook/geos/sf'html (last

visited Apr. 19, 2002).
48. Dorrington, supra note 22, at 5.

49. Id. at 6.
50. Id.
51. Id.
52. Rachel Swarns, A Bold Move on AIDS in South Africa, N.Y. TIMES, Feb.
5, 2002, at A10.
53. Treatment Action Campaign, Bredell Consensus Statement of the
Imperative to Expand Access to Anti-Retroviral (ART) Medicines for Adults
and Children with HIVIAIDS in South Africa (Nov. 19, 2001), at

http://www.tac.org.za/Documents/Statements/bredell3.pdf.
19, 2002) [hereinafter Bredell Consensus Statement].

54. Id.

(last visited Apr.
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active adult population, one of the effects of the epidemic has been
an increasing shift in the ratio of deaths from those over fifty to
those aged fifteen to forty-nine, between 1990 and 2000."5 The
effect on children is devastating. Under current estimates, 70,000
children are infected with HIV each year.56
In Soweto, a
Johannesburg Township, fifty percent of the pediatric admissions
and two-thirds of the deaths of children are due to HIV."7
III.

THE FUTURE

If obtaining an accurate account of the current situation is
fraught with methodological uncertainties, projections of future
scenarios are even more hazardous. Some of these uncertainties
include the commitment of the South African government to
educational programs and the availability of anti-retroviral drugs
for pregnant women. However, certain actuarial projections based
on tested methods and relied upon by the insurance industry are
available at least to provide a set of educated portrayals of the
future landscape based upon different a set of variable factors.
Under the most optimistic set of assumptions, the projections are
catastrophic. In the next ten years, there will be between four and
seven million AIDS related deaths and life expectancy will drop
between five and sixteen years from the current age of fifty-five.'
The AIDS Unit of the Actuarial Society of South Africa has
provided two charts projecting the future impact of HIV/AIDS on
South Africa. These charts are appended to this Article. Like
most data relating to HIV/AIDS, they are not without controversy.
Although they are disputed by certain South African governmental
officials, those figures are based on the South African
government's own statistics from their antenatal clinics. They are
also used by the government institutes like the Medical Research
Council and by the insurance industry in South Africa.
The two charts differ only in that one of them is based on the
assumption that there will be no change in the behavior and the
response of the South African government regarding HIV
prevention. The first chart is entitled "no change scenario."
(Figure 1).
The second chart assumes moderate changes in
55. Dorrington, supra note 22, at 17.
56. Bredell Consensus Statement, supra note 53.
57. Glenda Grey M.D., Fighting the Epidemic at Ground Zero: Combating
HIV Infection in Soweto, South Africa, HIV/AIDS Annual Update (2001),
available at Medscape.com, http://www.medscape.com/viewarticle/418662 (last

visited Apr. 19, 2002).
58. Dorrington, supra note 22, at 24. The Dorrington report cites the
United States Bureau of the Census as forecasting a higher rate of infection
and a lower life expectancy rate in the United States compared to South Africa
in 2010. However, the authors are skeptical about these figures because the
World Health Organization estimated in 1999 that life expectancy in South
Africa would decline from sixty to forty-three years.
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governmental response and the population's sexual behavior. The
second chart is entitled "change scenario." (Figure 2). Moderate
change means that in five years, the government will provide
intervention to prevent mother to child transmission in ninety
percent of the cases, and that in five years there will be treatment
to decrease sexually transmitted diseases by fifteen percent. In
five years, there will also be a doubling of condom use and a
decrease of new sexual partners by fifteen percent.
Under this moderate change scenario, one observes from the
second chart that the total HIV infections will reach a peak in the
year 2005. 7.086 million people will be living with HIV in South
Africa out of a population of forty-seven million, which is about
fifteen percent of the total population, or just over a quarter of the
adults between twenty and fifty-five years old. That is, the
Actuarial Society of South Africa predicts that three years from
now, a quarter of the adults between ages twenty and sixty-five
will be living with AIDS in South Africa. Deaths will reach a peak
in the year 2010 when 712,535 people will die that year of AIDS
related diseases.
In the decade between 2000 to 2010,
accumulated deaths are projected to be just under five million
people. In that decade, there will also have been over one and a
half million AIDS orphans.
In terms of life expectancy, by the year 2011, life expectancy
will have dropped thirteen years to forty-three from the present
life expectancy of fifty-six.
If there is no change in sexual behavior, or if there is no
change in the government's response to HIV/AIDS, the total HIV
infections will reach a peak in 2008. There will be 7.7 million
people living with HIV in South Africa, which is 16.2 percent of
the total population and 27.2 percent of adults between twenty
and sixty-five. Deaths will reach a peak in the year 2011 when it
is projected that 780,000 will die of AIDS related deaths that year.
The accumulated AIDS deaths from the year 2000 to 2010 are
projected to be 5.23 million. To put this in perspective, the
difference in accumulated deaths between no change and moderate
change is roughly fifty times the number of people who died in the
World Trade Center on September 11, 2001. In that decade also,
seven years from now, there will be 1,530,000 AIDS orphans. Life
expectancy is projected to drop sixteen years.
These statistics mask several social facts. Firstly, HIV/AIDS
is not a gay disease. The infection rates affect all sections of South
African society. Secondly, HIV/AIDS is poverty and race related
disease. There is an extremely disproportionate impact on poor
and non-white communities in South Africa. There is also a
city/rural gap. The health delivery infrastructure, while advanced
compared to many developing nations, is heavily weighed in favor
of urban areas and almost completely unavailable to rural areas.
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While this gap is also interrelated to race and poverty issues, one
needs to pay attention to this geographical disparity. This is
important since much of the rhetoric opposing the provision of
anti-retroviral drugs to developing countries is based on the lack of
an effective healthcare infrastructure. That cannot be said of
South Africa, where such an infrastructure does exist, but mostly
for the urban privileged.
Why has it been so difficult then to address this catastrophe?
The lack of political will stands out as a major obstacle. President
Thabo Mbeki's ambivalence about the scientific link between HIV
infection and AIDS translates to governmental apathy, confusion
and paralysis. 9 Racism plays a role. Forced migrant labor is one
of the many apartheid legacies that contributed to the spread of
HIV/AIDS from the mainly white male population to the African
male and female populations. Under this system, black laborers
had to have special passes to work in jobs where the white
population lived. Black men were segregated from their wives and
often lived in huge hostels, leading to a break up of the family
system. Numbers of sexual partners increased resulting in an
increase in multiple transmission routes. Continued patriarchal
attitudes towards women and women's right to control their bodies
and reproduction also stand in the way of reducing transmission.
State educational efforts have also been ill conceived.
The government in South Africa admonished the citizens
through the so-called ABC Prevention Program. This program
firstly stressed abstinence. As a secondary measure, the program
urges citizens to "be faithful." Thirdly, if one is not or cannot be
faithful, the program urges the use of condoms. The underlying
message is that anyone who uses a condom or insists that one's
partner use a condom is therefore either unfaithful, promiscuous
or doesn't trust one's partners. These messages are, of course,
highly resisted by women in South Africa.
Another obstacle standing in the way of addressing HIV/AIDS
transmission is stigma. Like other cultures, AIDS is identified as

59. de Vos, supra note 25. South African President Thabo Mbeki is not the
only governmental impediment to effective HIV/AIDS policy implementation
and treatment in the South Africa. Peter Mokaba has expressed similarly
extreme views. Mokaba is a current South African member of Parliament and
was also a former anti-apartheid leader. Mokaba has commented that "H.I.V.?
It doesn't exist," and
The kind of stories that they tell that people are dying in droves? It's
not true. It's not borne out by any facts ... [We cannot allow our people
to be guinea pigs ... Anti-retrovirals, they're quite dangerous. They're

poison actually. We cannot allow our people to take something so
dangerous that it will actually exterminate them. However well
meaning, the hazards of misplaced compassion could lead to genocide.
Rachel L. Swarns, An AIDS Skeptic in South Africa Feeds Simmering Doubts,

N.Y. TIMES, Mar. 31, 2002, § 1, at 4.
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a sexual and gay disease in South Africa. There is a strong
cultural aversion to speak about sexually transmitted diseases.
Combined with homophobia, those diagnosed with AIDS are
closeted about their disease, and those who die from AIDS do not
have the cause of death disclosed. This creates a culture of silence
around HIV and AIDS, a silence that works against educational
and consciousness raising efforts.
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INTRODUCTORY REMARKS: AIDS AND
GLOBALIZATION-THE QUESTION
PRESENTED
ANDREW L. STRAUSS*

Welcome to our panel on International AIDS. Many of you
are probably familiar with the chaos theorist, Edward Lorenz, who
described what came to be called the butterfly effect, that the
world of nature is so interdependent that a butterfly flapping its
wings in Beijing could result in an eventual storm in New York
City.60 Globalization reinforces more than ever before that one
aspect of nature, the human community, is interconnected, highly
interconnected. In a largely borderless world, what one of us does,
what one of us thinks, what happens to one of us affects all of us.
And the topic of today's panel, the horror of AIDS, makes this
For what better
much more than a mere abstraction.
demonstration really of the butterfly effect than the possibility
that a monkey somewhere in the world bit one person and that
this led to what eventually has become the AIDS crisis.6'
The charge of the panel this morning is to specifically
examine "International AIDS as a Case Study in the Challenges of
Globalization." If the disease knows no borders, then shouldn't
our solutions as well? This raises a host of questions for our panel
to discuss. How do you create an effective strategy for dealing
with the spread of a truly transnational pandemic? The question
of subsidiary. What should be done at the level of the state and
What is the role for
what should be done internationally?
should the
How
intrusive
rights?
human
international
seem
governments
where
in
countries
international community be
policies?
irrational
wholly
or
even
to be following wrong-headed
Do we at this point have the basic institutional infrastructure to
accomplish an effective global strategy? Questions of distributive
justice abound as well. Clearly, the disease knows no boundaries,
but why is it that the poor, and the dispossessed, and the
marginalized are its greatest victims? What are the obligations of
specific industrial sectors such as drug companies or of wealthy
citizens in general to help? What do ongoing debates about
Professor of Law, Widener University School of Law.
60. See JAMES GLEICK, CHAOS: MAKING A NEW SCIENCE 20-23 (Penguin
Books) (1987).
61. For a discussion of this and other theories of the origins of the AIDS
epidemic, see JAD ADAMS, AIDS: THE HIV MYTH 177-79 (St. Martin's Press
1989) (identifying the monkey bite theory as enjoying the most support).
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intellectual property rights and economic theory have to contribute
to this discussion?
These are the questions that our panel will turn to. Our first
speaker, John Culhane, will look at how lessons learned in the
United States can be adapted to the international fight against
AIDS. Our next speaker will be Mark Wojcik who will discuss the
applicability of the international human rights paradigm to the
fight against AIDS. Following, Allyn Taylor will focus primarily
on institutional and resource issues, specifically to what extent are
international public, private partnerships called for in the fight
against AIDS. Finally, Peter Kwan and Pierre de Vos will look at
South Africa, one of the hardest hit countries in the world as a
case study in the global fight against AIDS. First, Peter will lay
the foundation by describing the problem, and then Pierre will
discuss legal strategies for dealing with it.
I would like to now tell you a bit about our distinguished
panel. John Culhane is a professor of law at Widener University
School of Law, visiting professor of law at California Western
School of Law for the Spring of 2002, and lecturer at Yale
University School of Public Health. He teaches public health law
at all three schools. He has written extensively on the subject of
tort law, public health law and the rights of same sex couples, and
is currently finishing work on an article on HIV in the workplace.
Professor Culhane is a graduate of the William and Mary College
and Fordham Law School.
Mark Wojcik is an associate professor of law at
the John
Marshall School of Law in Chicago. He is active in the ABA
Section on International Law and Practice where he is a co-chair
of the International Human Rights Committee and vice chair of
the International Health Law Committee. He has written articles
and book chapters on the legal aspects of HIV and AIDS for more
than fifteen years. He is presently on sabbatical in Honolulu.
Allyn Taylor is a senior health policy advisor at the World
Health Organization [WHO]. Her primary work at the WHO
involves serving as the senior legal counsel on the WHO
Framework Convention on Tobacco Control. She is also a member
of the adjunct faculty at the John Hopkins School of Hygiene and
Public Health. She currently serves as a chair of the International
Health Law Interest Group of the American Society of
International Law. Dr. Taylor holds a JD from the University of
California, Berkeley, Boalt School of Law and a doctorate in public
international law from Columbia University School of Law where
she was a Ford Foundation Fellow.
Professor Peter Kwan studied law and philosophy at the
University of Sydney where he completed his bachelor and
masters degree in law, magna cum laude. He also has a masters
degree in law from Columbia University where he was an article

2002]

Dealing with InternationalAIDS

editor for both the Journal of Transnational Law and the Journal
of Chinese Law. Professor Kwan has served as chair of the
Association of American Law Schools Section on Law and
Humanities and is a chair elect of the AALS Section on Sexual
Orientation and Gender Identity. Professor Kwan is currently
teaching as a visitor at the University of Hong Kong, Department
of Law.
Professor Pierre de Vos teaches constitutional law and
international human rights at the law faculty at the University of
Western Cape in South Africa.
He holds degrees from
Stellenbosch University, Columbia University and the University
of Western Cape. He has published academic articles on a wide
variety of topics including election law, the right to equality, same
sex adoption and relationships, social and economic rights and
legal philosophy.
In 1994, he also published a novel, Slegs
Blanks/Whites Only which was nominated for the CNA Literary
Award.
As you can see our panel is uniquely qualified to help us at
least begin to draw some conclusions on "International AIDS as a
Case Study in the Challenges of Globalization."

PUTLIC-PRIVATE PARTNERSHIPS FOR
HEALTH: THE UNITED NATIONS GLOBAL

FUND ON AIDS AND HEALTH
ALLYN L. TAYLOR*

Today I will review some of the significant developments in
global efforts to combat the AIDS pandemic during the last year,
including the establishment of a new United Nations ("UN")
Global Fund on AIDS and Health ("Global Fund"). Before I begin,
I would like to express my appreciation to Professor Strauss for
the opportunity to participate on this timely panel. I would also
like to note that the views that I am presenting are my own and
not necessarily those of the World Health Organization [WHO].
Despite the grim scenario of the AIDS pandemic, there have
been critical developments in the last year that suggest that the
global community has finally begun to recognize that universal
access to prevention, treatment and care for HIV/AIDS is not only
technically possible, but also a human rights imperative. A year
ago AIDS drugs in Kenya and Ukraine cost the same as in the
United States, around $10,000 a year.
Over the last year,
Health Policy Advisor, World Health Organization; Adjunct
Assistant
Professor, Johns Hopkins Bloomberg School of Hygiene and Public Health;
J.S.D. (2000), Columbia University School of Law; J.D. (1987) University of
California School of Law (Boalt Hall).
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however, there have been numerous and significant price drops for
developing countries with one generic drug-maker now offering its
Multinational
triple-combination therapy for $350 a year.
pharmaceutical companies, responding to competition from
generics and widespread public criticism, have slashed prices for
poor nations, although-at a little over $1,000 per year per person
-still far out of reach for most poor states.
In addition, a year ago, many argued that unsophisticated
patients in remote areas could not master a complex antiretroviral regimen. Today, taking AIDS medicine is simpler and a
number of small pilot clinics in poor countries have found a way to
treat poor people successfully.
The global community has also, for the first time, put AIDS
The
on the forefront of the international political agenda.
Declaration on the TRIPS Agreement [Agreement on TradeRelated Aspects of Intellectual Property Rights] and Public Health
adopted at the World Trade Organization [WTO] Ministerial
Summit in Doha on November 14, 2001, clarified and reaffirmed
states' rights to declare national emergencies under the WTO
TRIPS Agreement and institute compulsory licensing in the case
of public health emergencies, including AIDS. In June 2001, the
United Nations adopted a "Declaration of Commitment" on AIDS
during a special three-day session of the UN General Assembly.
Although lacking in teeth, the Declaration does set concrete
targets and timelines at the national and international levels to
fight AIDS.
Overall, this last year has marked an important shift in the
global, technical, legal and political capacity to address the AIDS
pandemic. Discussion about global prevention, treatment and care
for those suffering from or affected by AIDS is no longer simply an
academic debate. The critical challenge for 2002, therefore, is to
enhance global financial capacity to provide comprehensive
prevention, treatment and care services to fight AIDS. This
struggle for money is no small feat and it is not simply about pills.
The United Nations has estimated that seven to ten billion dollars
is required annually to address the burden of AIDS in developing
and middle income states.
The establishment of a well-endowed United National Global
AIDS and Health Fund at the June 2001 Special UN AIDS
Summit is, therefore, perhaps the most significant recent
development in global AIDS policy. Although far short of the
resources called for by the UN, the Global Fund will almost double
the world's spending on AIDS this year as compared to last, with
$1.6 billion committed to the Global Fund thus far.
As reflected in the remarks of my colleagues on this panel
today, academics and practitioners alike have high hopes that the
Global Fund will be an effective mechanism to relieve the profound
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impact of AIDS in developing states. However, little public
information is available about the Global Fund and it has been
subject to virtually no independent scrutiny, despite the fact that
it is set to commence operations this month. Consequently, there
are a number of outstanding questions regarding the potential and
limitations of this new institution.
What we do know is that the Global Fund is a product of the
personal vision of the UN Secretary-General Kofi Annan, who first
proposed the creation of this new war chest last April as a vehicle
whereby resources from public and private donors could be
channeled quickly and effectively to address prevention, treatment
and care of AIDS, malaria and tuberculosis in developing
countries. The Global Fund is being designed to serve purely as a
financial instrument, not an implementing agency. The Global
Fund is intended to serve as a means for mobilizing, managing
and disbursing new and additional resources. Trusteeship of the
Global Fund has been entrusted to the World Bank, which
manages numerous global funds, most notably in the
environmental arena.
If utilized effectively, the Global Fund holds the promise of
bringing anti-retroviral therapy as part of a package of
comprehensive AIDS prevention, treatment and care services to
poor people around the world. Indeed, the Global Fund could
make major inroads against this disease by negotiating for the
lowest possible prices for therapy on behalf of countries that are
too small or poor to have clout with manufacturers. The Global
Fund could also negotiate and pay for generic copies of drugs
patented in rich countries to alleviate the suffering in poor
countries.
However, as an effective instrument of health policy, the fund
faces numerous external and internal obstacles. The external
challenges, including the globalization of the AIDS pandemic, the
continuing conflict between developed and developing countries on
patented medicines and financial commitment are largely well
known.
Less well appreciated are the internal challenges faced by the
Global Fund. In design and operation, the Global Fund has been
conceived as a unique hybrid of an increasingly popular institution
known as a "global public-private partnerships." Although there
are many definitions, global public-private partnerships are
generally understood as involving some type of a collaborative
relation between a corporation or industry organization and a
public international organization that transcends national
boundaries. Many of these partnerships also include other parties,
including bilateral or civil society organizations.
The Global Fund has a distinct emphasis on public-private
partnerships in both the organization of its management and its
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operational policy. Indeed, the structure of the Global Fund is
unprecedented. Although established by an intergovernmental
organization, it is to be operated like a private foundation. The
Global Fund has been created as an independent legal entity. In
late January, the Permanent Board of the Global Fund, which is
entrusted with making all financial commitments, will hold its
first session. The Board will include an equal number of donor
and developing countries, with seven seats each. In an exceptional
move, the Board will also include two non-governmental
organizations (NGOs) and two private sector voting seats. In
addition, background information on the operation of the Global
Fund specifically states that it will have an intense emphasis on
public-private partnerships in targeting resources.
Although collaboration with the private sector on health
matters was virtually unheard of a decade ago, in the last ten
years public international organizations have entered into a
remarkably diverse array of partnerships with the commercial
sector; varying with regard to participants, legal status,
governance, management, contributions and operational roles. A
large variety of such partnerships have arisen to strengthen
product development, product donation or distribution, and the
general strengthening and coordination of health services.
Donation/distribution ventures, such as for leprosy multi-drug
therapy, are, perhaps, the most well known public-private
Contributions from
partnerships in the health field.
pharmaceutical companies have also included involvement in
supportive services to ensure appropriate distribution and
effective use.
Other partnerships have focused on increased research and
of drugs and vaccines for diseases that
development
disproportionately affect the poor. In the area of AIDS there have
been a number of public-private partnerships aimed at
strengthening health services and improving coordination, most
notably the UNAIDS initiative, Accelerating Access to HIV Care,
Support and Treatment, in partnership with five pharmaceutical
companies.
There are about seventy public-private partnerships for
health active today and there is clearly a wide spectrum of
relationships embraced by the expression "public-private
partnership" in the health context. However, to date, there has
been little systematic evaluation of how these partnerships
function and what constitutes good practice. Consequently, it is
difficult to analyze the potential strengths and weaknesses of the
Global Fund relative to other public-private partnerships for
health.
In principle, the Global Fund's emphasis on public-private
partnerships in resource allocation decisions at the country level
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appears sound. Although a number of commentators have been
highly critical of the idea of partnerships with the private sector in
general, in international health it is widely recognized that
intractable health problems require innovative collaborations of
different sectors to achieve a synergistic combination of strengths,
resources and expertise. Prevention, care and treatment of AIDS,
as well as alleviating the impact of the epidemic, require largescale multisectoral planning and coordination among diverse
partners.
Public-private partnerships can also bring major resources
into international public health efforts to combat AIDS at the
country level and have the potential to benefit large populations.
Health service delivery and other programs can clearly benefit if
public sector agencies work in collaboration with the private sector
in areas where the public sector lacks expertise and experience.
Notably, one of the first proposed projects being considered by
the Global Fund provides a case in point for the potential benefits
of collaboration with the private sector. The Transitional Working
Group for the Global Fund has examined a proposal to provide
anti-retrovirals to Africa's networks of hospitals, mission
hospitals, health care centers and rural clinics.
Clearly,
corporations such as Coca-Cola, which sat on the Transitional
Working Group for the Fund, may have better distribution
networks throughout many poor countries than either the United
Nations or national governments.
Consequently, such a
partnership between the private and public sectors may be able to
administer drugs to people in need soon and without being
hindered by complex governmental or intergovernmental
bureaucracy.
However, cause for concern arises as to whether private
industry is appropriately included on the Board of the Global
Fund, which is charged with financial decision-making. Inclusion
of corporations on the Board of the Global Fund gives private
industry the exceptional right to participate in global public policy
agenda setting, policy formulation and implementation. 62 It is

62. The Board of the Global Fund will include an equal number of seats for
donor and developing countries of seven seats each. The Board also includes
two NGO and two private sector donor seats. WHO, UNAIDS and The World
Bank will hold non-voting seats on the Board. In addition, the Board will
include a person living with AIDS, tuberculosis or malaria in a non-voting

seat. The decision making process includes an independent technical panel
comprised of experts.

These experts will review all proposals and make

recommendations to the Board. Press Release, The Global Fund to Fight
AIDS, Tuberculosis and Malaria, Planning Phase for Global Fund to Fight
AIDS, TB and Malaria Concludes With Agreement on Basic Foundations (Dec.
17, 2001), at http://www.globalfundatm.org/news-pr5.html (last visited Apr. 5,

2002). The Board will attempt to reach consensus in all cases. In the absence
of consensus, the Board will utilize a voting procedure based on a two-thirds
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certainly feasible that private sector efficiency and expertise could
strengthen the planning targeting and implementation of the
Global Fund as compared to the bureaucratic inefficiency of the
United Nations and the specialized agencies. However, public
health policymaking may not be an appropriate area of
partnership.
As Buse and Waxman have noted, it must be kept in mind
that ultimately the aims and values of public international
organizations and corporations diverge. 3 The aim of the United
Nations in general is to promote universal values of tolerance,
freedom, justice, and equality found within the UN Charter. The
core goal of the Global Fund is in particular to reduce infection,
illness and death in countries in need. At the other end of the
spectrum are the goals of private industry. The ultimate goal of a
publicly held corporation is centered on maximizing profits to
increase shareholder wealth.
Profit maximization may interfere with the goals of global
public health in AIDS or in other contexts. Indeed, to return to
the promise of the Global Fund described earlier, it is reasonable
to question whether large industry participants on the Board
would consider funding any projects involving the generic
manufacture of patented drugs or which involve bulk purchase of
anti-retrovirals to increase the market power of poor countries,
even if consistent with the proscriptions of the WTO.
Ultimately, there may be a real concern that the goals of the
United Nations in establishing the Global Fund could be subverted
as policies, strategies and resource allocation decisions are either
driven or subject to approval by industry. The structure of the
Global Fund raises significant questions of global health
governance. Traditional support for the United Nations could be
undermined if this partnership erodes confidence in the credibility
and impartiality of the Organization. As Buse and Walt have
noted, the United Nations could be compromised if private sector
collaboration undermines the goodwill of those states who believe
in a multilateralism in which governments, not corporations, are

majority from each of the two major groups represented on the Board. The

two major groups on the Board are donors (including public and private sector
participants) and developing countries (including NGOs). The Global Fund to
Fight

AIDS, Tuberculosis

and

Malaria,

Questions and Answers, at

http://www.globalfundatm.orglquestionsanswers.html

(last visited Apr. 5,

2002). As a consequence of the voting structure, private sector members of the

Board do not have the voting power to block proposals supported by at least
six of the donor countries. However, the potential significance of the voting
power and the political influence of the private sector on the Board cannot be
dismissed.
63. KENT BUSE & AMALIA WAXMAN, 79 BULL. OF THE WHO 748, PUBLICPRIVATE HEALTH PARTNERSHIPS: A STRATEGY FOR WHO 750 (No. 8, 2001),

availableat http://www.who.intfbuletin/pdf.PDF (last visited Apr. 5, 2002).
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the decision-makers."
The parameters of any public-private partnership should be
situated within the context of the appropriate role of public
international organizations. The inclusion of private industry on
the Board of the Global Fund raises the question of whether the
traditional distinction between the public and the private sector's
aims and responsibilities have become or may become distorted.
The goal of this presentation is not to answer this question, but to
stimulate critical thought about the Global Fund as it commences
its operations.

HIV/AIDS IN SOUTH AFRICA: THE GOOD,
THE BAD AND THE UGLY
PIERRE DE VOS*
INTRODUCTION
I want to start by thanking the sections for inviting me to this
conference. It is a bit weird to be in the Versailles Room with all
these opulent and expensive chandeliers speaking about
HIV/AIDS in South Africa, but one must do what one must do. In
my talk, I will try to highlight both the positive and the negative
aspects of the [South African] government's reaction to the AIDS
pandemic in the country. I will also try to show how the
international human rights discourse might be used in conjunction
with domestic constitutional law in South Africa to advance the
cause of the prevention of HIV and the protection and treatment of
people living with HIV/AIDS.
I.

CONSTITUTIONAL AND LEGAL PROTECTION FOR PEOPLE LIVING

WITH HIV/AIDS
The good news is that South Africa has one of the most
progressive Constitutions in the world. 5 It contains an equality
clause that guarantees equality before the law and the right to
equal protection and benefit of the law and also prohibits "unfair"
discrimination on any ground, including those listed explicitly in
section 9(3), which are, amongst others, race, sex, gender, sexual
64. K. BUSE & G. WALT, 78 BULL. OF THE WHO 699, PUBLIC-PRIVATE
HEALTH PARTNERSHIPS: PART

II

- WHAT ARE THE HEALTH ISSUES FOR GLOBAL

GOVERNANCE? (No. 5, 2000), available at http://www.who.int/bulletin/pdf.PDF
(last visited Apr. 5, 2002).

* Associate Professor of Law, University of Western Cape; BComm (Law);
LLM, University of Stellenbosch; LLM, Columbia University; LLD, University
of Western Cape.
65. S. AFR.CONST. (Constitution Act 108, 1996).

Dealing with InternationalAIDS

2002]

orientation and disability.66 Although HIV/AIDS status is not
explicitly listed in section 9(3), the Constitutional Court recently
held that HIV/AIDS status was indeed a ground on which a person
could be unfairly discriminated against.67
In Hoffmann v South African Airways, the court found that

unfair discrimination in terms of section 9(3) results where the
impact of the discrimination is such that it impairs the human
dignity of the person concerned.68 People living with HIV/AIDS
are a minority group, exposed to intense prejudice and thus
subjected to systematic disadvantage and discrimination. The
court continued:
In view of the prevailing prejudice against HIV positive people, any
discrimination against them can, to my mind, be interpreted as a
fresh instance of stigmatization and I consider this to be an assault
on their dignity. The impact of discrimination on HIV positive
people is devastating. It is even more so when it occurs in the
context of employment. It denies them the right to earn a living.
For this reason, they enjoy special protection in our law. 69
This decision means that people living with HIV/AIDS now

66. Section 9 of the South African Constitution states:
(1) Everyone is equal before the law and has the right to protection
and benefit of the law.
(2) Equality includes the full and equal enjoyment of all rights and
freedoms. To promote the achievement of equality, legislative and
other measures designed to protect or advance persons, or categories
of persons, disadvantaged by unfair discrimination may be taken.
(3) The state may not unfairly discriminate directly or indirectly
against anyone on one or more grounds, including race, gender, sex,
pregnancy, marital status, ethnic or social origin, colour, sexual
orientation, age, disability, religion, conscience, belief, culture,
language and birth.
(4) No person may unfairly discriminate directly or indirectly
against anyone on one or more grounds in terms of subsection (3).
National legislation must be enacted to prevent or prohibit unfair
discrimination.
(5) Discrimination on one or more of the grounds listed in subsection
(3) is unfair unless it is established that the discrimination is fair.
Id. ch. 2, § 9.
67. See Pierre de Vos, Equality for All? A Critical Analysis of Equality
Jurisprudence of the Constitutional Court, 63 TYDSKRIF VIR HEDENDAAGSE
ROMEINs-HOLANDSE REG. 62, No. 1 (2000) (explaining the South African

Constitutional Court's equality jurisprudence).
68. Hoffman v. S. African Airways, 2000 (11) BCLR 1211, 1 28 (CC),
available at http://www.concourt.gov/za/judgments/2000/saa.pdf (last visited
Apr. 5, 2002).
69. Id.
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have almost exactly the same constitutional protection against
unfair discrimination as people who fear discrimination based on
race, sex or gender. 0 People living with HTV/AIDS in South Africa
are not only protected by the Constitution, which, after all, is
difficult and expensive way of protecting one's rights.
The decision of the court was foreshadowed by several
provisions in other legislation adopted since the advent of the
South African Constitution explicitly protecting people living with
HIV/AIDS from exploitation and discrimination. For example,
labor legislation, which came into effect in 1999, explicitly
mentions HIV status as a ground on which an employer may not
discriminate when hiring, promoting or firing an employee.7' The
same act also prohibits the testing of an employee for HIV status
unless the Labour Court, in strictly defined circumstances,
The National
determines that such testing is justifiable."
Department of Education has also issued a national policy on
HIV/AIDS, which, amongst other things, prohibits unfair
discrimination against learners, students and educators with
HIV/AIDS,' while the National Department of Health has issued a
national policy on testing for HIV.7 4 Furthermore, the Medical
Schemes Act obliges all medical schemes to provide at least a
minimum cover for HIV positive persons. 7'
It is therefore clear that a strong legal framework exists to
protect people living with HIV/AIDS from discrimination and
exploitation.
This protection extends beyond the protection
against discrimination by state institutions, and also covers many
70. de Vos, supra note 67, at 7. See also Harksen v. Lane, 1997 (11) BCLR
1489, 1 47 (CC), available at 1997 SACLR Lexis 20, at *61 (stating that "in the
case of dicrimination on an unspecified ground, the unfairness must still be
established before it can be found that a breach.., has occurred."). People
living with HIV/AIDS now have nearly the same constitutional protections
against discrimination as that based on race or gender because a person living
with HIV would have to carry the burden of proof to show that the
discrimination against him or her was indeed fair, while a person who alleges
discrimination on one of the grounds explicitly listed in section 9(3) will only

have to show that a distinction was made on one of those listed grounds and it
will then be assumed to constitute unfair discrimination.
71. § 6 (1) of Employment Equity Act 55 of 1998, available at
http://www.parliament.gov.za/acts/1998/act55-98.htm (last visited Mar. 23,

2002).
72. Id. §§ 7(2), 50(4).
73. § 3(4) of National Education Policy Act 27 of 1996, available at
http://www.parliament.gov.za/acts/1996/act96.027 (last visited Mar. 23, 2002).

74. See Schedule of National Policy for Health Act 116 of 1990, available at
http://196.36.153.56/doldocs/notices/1999/not99-1479.html (last visited Mar.
23, 2002) (stating that the national policy on HIV testing is to balance
informed consent with privacy).

75. § 29(1)(n) of Medical Schemes Act 131 of 1998, available at
http://www.polity.org.za.govdocs/legislation/1998/act98-131.html (last visited
Mar. 23, 2002).
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instances of "private" or "semi-private" forms of discrimination. In
this sense, South Africa's approach to the HIV/AIDS pandemic can
be viewed as commendable. Unfortunately, other aspects of the
current government's program are not nearly as laudable.
II. PREVENTION OF HIV TRANSMISSION
The government has admitted that an extensive, culturally
relevant and well-balanced HIV transmission prevention program
would require the state to take several steps to limit the risk of
HIV infection. Such steps would include steps to educate the
population about the need to use condoms during sexual
intercourse and to go for early treatment of other sexually
transmitted diseases. It would also include medical interventions
such as provision of anti-retroviral drugs to individuals after
exposure to the HIV virus due to medical accidents or rape and
sexual assault, and strategies to reduce the transmission of HIV
from HIV positive mothers to their children through antiretroviral programs. 76
While the government's HIV/AIDS
educational programs are quite comprehensive and generally
viewed to be relatively effective, its approach to medical
interventions to prevent HIV transmission seems less than logical.
The good news is that where healthcare workers in public
health facilities are exposed to HIV in the course of their duties,
and are therefore at risk in becoming HIV positive, the
Department of Health will provide free access to anti-retroviral
drugs. Although the risk is relatively low, the Department of
Health has laid down clear guidelines to deal with this risk 7
According to these guidelines, the most effective way to deal with
such high-risk exposure is to administer a combination of antiretroviral drugs within one or two hours after exposure. 78 To avoid
delays in starting this treatment, the guidelines recommend that
76. See SOUTH AFRICAN DEPARTMENT OF HEALTH, THE SOUTH AFRICAN
GOVERNMENT'S RESPONSE TO THE HIV/AIDS EPIDEMIC; CONTROVERSIES AND

PRIORITIES, §§ 1.1-1.3, available at http://196.36.153.56/doh/aids/docs/gov-

aids.html (last visited Mar. 23, 2002) (identifying necessary guidelines in
response to the South African HIV epidemic and other communicable diseases)
[hereinafter THE SOUTH AFRICAN GOVERNMENT'S RESPONSE TO THE HIV/AIDS
EPIDEMIC].
77. See SOUTH AFRICAN DEPARTMENT OF HEALTH, MANAGEMENT OF
OCCUPATIONAL EXPOSURE TO THE HUMAN IMMUNODEFICIENCY VIRUS (HIV)

(1999),

911.5, available at http://www.doh.gov.za/aids/docs/management.html

(last visited Mar. 23, 2002) (identifying the "average risk of HIV infection from
all types of reported percutaneous exposure" as approximately 0.3%).
78. Id. 1 3.4. The guidelines prescribe Zidovudine (AZT) administered in

combination with Lamivudine (3TC). Id. at app. 1. It is recommended that
Indinavir be added for very high-risk exposures, for example where high

volumes of blood is involved or where a deep injury has occurred and if the
source patient has been on Zidovudine for longer than six months. Id. 1 3.3,
app. 1.
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starter packs of the relevant drugs be made available in all
healthcare settings. It is also recommended that the treatment
should be continued for up to four weeks. Supportive counseling
should also be made available to the exposed health care worker."9
The bad news is that this policy is not extended to individuals
who are raped or otherwise sexually assaulted and who may have
been exposed to HIV infection. Although it has been shown that
the administering of anti-retroviral drugs immediately after the
exposure and follow up treatment for two to six weeks after the
assault may reduce the possibility of HIV transmission to the
survivor of the rape or sexual assault, it appears that the official
state policy prohibits the provision of anti-retroviral drugs in state
hospitals to the survivors of sexual assault.8 ° In at least one of the
nine provinces, Mpumalanga, the member of the Executive
Council ("MEC") for health has gone further by evicting a
volunteer NGO [non-governmental organization] from the state
hospital premises for providing anti-retroviral drugs such as AZT
and 3TC to survivors of rape and sexual assault.81
The state has also refused to provide access to anti-retroviral
drugs to all HIV positive pregnant mothers at birth to reduce the
mother-to-child transmission of HIV. This is extremely perplexing
given the fact that mother-to-child (MTC) transmission of HIV is
the primary source of HIV infection in young children in South
Africa. Over ninety percent of HIV infections in children are
caused by transmission from mother to child. ' _ In the absence of

79. Id. 3.11.
80. See Mbulelo Baloyi, 'Sorry, No Drugs Here...',Independent Online, at

http://www.iol.co.za/general/news/newsprint.php?artid=ct2001120720201498
1A6161856 (last visited Mar. 19, 2002) (describing how a South African rape
crisis center denied a young South African woman anti-retroviral drugs
because the government prohibited such); Liz Clarke, Ethical War Looms after
Rape-Baby
AZT
Row,
Independent
Online,
at

http://www.iol.co.za/general/news/newsprint.php?artid=ct2002011119551894
P430282 (last visited Mar. 19, 2002) (describing the Northern Cape Health
MEC's criticism of local physicians who gave a nine-month old baby antiretrovirals after nine men gang-raped and sodomized her).
81. See Sizwe samaYende, Health MEC Evicts Anti-Rape Activists,

Independent
Online,
at
http://www.iol.co.za/general/news/newsprint.php?artid=ct2001051217401322
5R136168 (last visited Mar. 19, 2002) (quoting a South African MEC health
official's "persecution" of rape crisis volunteers because they poison "black
patients" and make "President Thabo Mbeki look like a fool"). The MEC also
argued that the NGO, Greater Nelspruit Rape Intervention Project
undermined the African National Congress and put her department in an
awkward position because rape survivors elsewhere in their province also

demanded anti-retroviral drugs. Id.
82. SOUTH AFRICAN DEPARTMENT OF HEALTH, PREVENTION OF MOTHER-TOCHILD HIV TRANSMISSION AND MANAGEMENT OF HIV POSITIVE PREGNANT
WOMEN,

3, available at http://196.36.153.56/doh/aids/docs/mtct.html (last

visited Mar. 19, 2002).

The transmission of HIV takes place during
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breastfeeding, about two-thirds of infections occur around the time
of delivery, with the majority of the remaining infections occurring
during the last two months of pregnancy. But in populations
where breastfeeding is the norm, it accounts for more than onethird of all transmission."
It is common cause that the number of infants infected with
HIV can be significantly reduced if certain steps are taken, most
notably, by the provision of anti-retroviral therapy to a pregnant
mother during childbirth and to the infant shortly after birth.'
Although research has shown that some of these regimes are more
effective than others, the most pertinent program for South
African use is associated with the drug marketed under the name
Nevirapine
by the pharmaceutical
company
Boehringer
Ingelheim.'
Nevirapine has been registered by the Medicines Control
Council (MCC) of South Africa for use to reduce the risk of MTC of
HIV intrapartum, that is, in the mother's womb before delivery.
Moreover, there is ample evidence that the drug could have some
success even without administering it in courses over weeks or
even months. According to the MCC, administering a single dose
of 200 milligrams to the mother during labor, preferably more
than two hours before delivery and a single dose of two milligrams
to the infant within forty-eight to seventy-two hours after birth
pregnancy, labor, delivery, or even after childbirth during breastfeeding, but
the vast majority of infections occur close to, or during, delivery and after
childbirth because of breastfeeding.

83. Id. 4.4(a). Other factors, although less important, also increase the
risk of mother-to-child HIV transmission, including the mother's immune
status, viral load, vitamin A deficiency, placenta infections, and method of
child delivery. Id. 4. In addition, behavioral risk factors during pregnancy
include cigarette smoking, drug use and unprotected intercourse. Id.
84. See Edward M. Connor et al., Reduction of Maternal-Infant
Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine
Treatment, 331 NEW. ENG. J. MED. 1173, No. 18 (Nov. 3, 1994) (stating that

"15 to 40 percent of infants born to infected mothers become infected in utero,
during labor and delivery, or by breast feeding"); Mary Lou Lindegren, M.D. et
al., Trends in PerinatalTransmission of HIV/AIDS in the United States, 282

J. Am.MED. ASS'N 531, No. 6 (Aug. 11, 1999) (delineating statistical results
that suggest "substantial declines in AIDS incidence were temporally
associated with an increase in zidovudine use"); Laura A. Guay et al.,
Intrapartumand Neonatal Single-Dose Nevirapine Comparedwith Zidovudine
for Preventionof Mother-to-Child Transmission of HIV-1 in Kampala, Uganda:

HIVNET 012 Radomised Trial, 354 LANCET 795 (Sept. 4, 1999) (providing
controlled study results of HIV-1 infant transmission frequency during labor
and the first week of life after Zidovudine and Nevirapine protocol).
85. State Now Says No Problem to AIDS Drug, allAfrica.com (Aug. 21,
2001), available at http://allafrica.com/stories/200108210131.html (last visited
Mar. 21, 2002). This is so, because the manufacturers of Nevirapine offered to
make the drug available to the South African government free of charge for a

period of five years for the purpose of reducing the risk of mother to child
transmission of HIV.
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will have a marked effect on the rate of transmission from mother
to child. 0
Given these facts, the failure of the state to provide those HIV
positive pregnant mothers who cannot afford private health care
with access to Nevirapine at birth, seems inexplicable. The policy
guidelines drawn up by the Department of Health and published
in May 2000 fails to refer at all to the provision of anti-retroviral
drugs to pregnant mothers during pregnancy and at delivery of the
baby and shortly after delivery to the baby. After a meeting
conducted on August [12-13], 2000, the Minister of Health and the
MECs of the nine provinces took a decision to expand the existing
"research sites" on Nevirapine to eighteen - two in each province."
It has been estimated that this pilot project, once fully operational,
would reach about ten percent of pregnant mothers in South
Africa.88 The reason for launching these pilot sites, according to
the minister, was to assess the operational challenges inherent in
the introduction of anti-retroviral regimen for the reduction of
vertical transmission in rural settings as well as in urban settings
in South Africa. It has not been launched to investigate the
efficacy of Nevirapine as it has been acknowledged "there is
sufficient evidence confirming the efficacy of various antiretroviral drug regimens in reducing the transmission of HIV from
mother-to-child."88_ The Department of Health has forbidden
doctors from prescribing Nevirapine to HIV positive pregnant
mothers outside of the eighteen pilot sites. Medical personnel
contravening this policy have been disciplined or even dismissed.
In December 2001, the Transvaal Provincial Division of the
High Court declared the state's current policies, actions and
omissions regarding the prevention
of mother-to-child
transmission of HIV to be in contravention of its duties in terms of
section 27 of the Constitution.0 In essence, the complaint in this
86. Treatment Action Campaign v. Minister of Health, Founding Aff.

68-

69 (Aug. 2001), available at http://www. tac.org.za/ (last visited Mar. 19, 2002).
87. THE SOUTH AFRICAN GOVERNMENT'S RESPONSE TO THE HIV/AIDS

EPIDEMIC,
supra
note
76,
1.3,
available
at
http://196.36.153.56/doh/aids/docs/gov-aids.html; Charlene Smith, Hospitals
Participating in the Programme, SANGONET (Jan. 26, 2001), at

http://www.sn.apc.orgwmail/issues/010126/OTHER39.html (last visited Mar.
19, 2002); Charlene Smith, Free Treatment for HIV+ Mums, SANGONeT (Jan.

26, 2001), at http://www.sn.apc.org/wmail/issues/010126/OTHER38.html (last
visited Mar. 19, 2002).
88. Persons are increasingly being reached because provinces such as

Guateng and Western Cape are now pilot sites for Nevirapine use. Smith,
Hospitals Participatingin the Programme,supra note 87.
89. SOUTH AFRICAN DEPARTMENT OF HEALTH, PROTOCOL FOR PROVIDING A
COMPREHENSIVE PACKAGE OF CARE FOR THE PREVENTION OF MOTHER TO

CHILD TRANSMISSION OF HIV IN SOUTH AFRICA, at (Q) (on file with author);
State Now Says No Problem to AIDS Drug, supra note 85.
90. See Treatment Action Campaign v. Minister of Health, No. 21182/2001,
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case was that the government continues to fail to "put in place a
policy and to implement a programme that will in due course
result in an integrated programme on a comprehensive basis,
despite repeated undertakings to that effect."91 _The government
had already agreed in 1997 that pilot studies had to be done and
that the end result should be to provide voluntary counseling and
testing and anti-retroviral drugs to HIV positive pregnant women.
But towards the end of 2001 the government had not yet budgeted
or implemented any plans for voluntary counseling and testing,
nor to provide the adequate information.92 In fact, on October 9,
1998, the government withdrew its support for a pilot project to be
launched in the province of Gauteng at five sites. Reasons were
given as cost, toxicity and the non-registration of Nevirapine. The
government policy also entailed a prohibition on all doctors in the
public health sector outside of the eighteen pilot sites of
prescribing Nevirapine to HIV positive pregnant mothers, even in
cases where such drugs were available and affordable by the
specific institution. The court found that the failure to act and the
prohibition on all doctors on prescribing Nevirapine in public
health facilities constituted an infringement on section 27 of the
Constitution.
The state is currently attempting to appeal this judgment
while the provinces of KwaZulu/Natal and Gauteng have
announced that they will be extending the existing pilot
programs. 93_ At this time, however, it is clear that despite the pilot
program, the Department of Health has no comprehensive, clearly
defined, written down plan of action to ensure that in the shortest
available time the treatment is made available to as many HIV
positive pregnant women as possible. Although the Department
at 60-61 (S. Afr. Transvaal Provincial Div. Dec. 2001) (holding that a health

program "that leaves everything for the future" violates section 27(2) of South
Africa's Constitution because such program fails to provide "the right to health
care"). Section 27 of South Africa's Constitution states:
(1) Everyone has the right of access to health care services,
including reproductive health care; ...
(2) The state must take reasonable legislative and other measures,
within its available resources, to achieve the progressive realisation
of each of these rights.
(3) No one may be refused emergency medical treatment.
S. AFR. CONST. (Constitution Act 108, 1996), ch. II (Bill of Rights), 27.
91. Treatment Action Campaign, Founding Aft.,
179 (Aug. 21, 2001),
available at http://www.tac.org.za/Documents/MTCTCourtCase/ccmfound.rtf

(last visited Apr. 5, 2002).
92. Id. 190.
93. KZN HIV+ Moms to Receive Nevirapine, iafrica.com (Jan. 22, 2002), at
http://www.iafrica.com/news/specialreport/aidsfocus/881286.htm

Mar. 21, 2002).

(last visited
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seems to be slowly moving towards a position where they will
expand the provision of Nevirapine to HIV positive pregnant
mothers, there is no comprehensive plan in place to ensure that

this happens as fast as possible.94

III. PROVIDING ACCESS TO TREATMENT FOR PEOPLE LIVING WITH

HIV/AIDS
While the Department of Health has prohibited state medical
institutions from providing access to anti-retroviral drugs to
people living with HIV/AIDS, it has instituted a policy in which
they have agreed that in state hospitals people should be treated if
they get opportunistic infections due to HIV infection." In South
Africa, as in many other developing countries, there is a big divide
between those people who have access to private health care
facilities and those who only have access to health care via the
The public healthcare system, while
public health system.
relatively good compared to most developing countries, does not
provide universal access, especially people living in rural areas
that often do not have resources to reach hospitals in towns and
cities. In such rural areas there are often no hospitals nearby and
people live up to 200 or 300 kilometers away from a hospital.
Where hospitals exist, there are not always the necessary drugs

94. There seems to be a general reluctance on the part of government
officials in the Department of Health to commit any plans to paper or to make
public announcements about any intended actions relating to the prevention
and treatment of HIV. Interview with Dr. S. Kariem, National Health
Committee Secretary, African National Congress, in Western Cape, South
Africa (Nov. 16 2001). Although Dr. Kariem was reluctant to speculate on the
reasons for this reluctance, the only reasonable conclusion to be drawn is that
the irrational antagonism displayed by President Thabo Mbeki regarding the
nature of HIV and AIDS and the need and effectiveness of anti-retroviral
drugs has scared officials into silence. The result is that officials are unwilling
to divulge such plans to the public, even where they are formulating plans for
the further extension of the provision of Nevirapine to HIV positive pregnant
mothers.
95. Individuals living with HIV often require access to treatment for
opportunistic infections caused or exacerbated by their diminished immune
systems. This means that they need access to other medicines designed to
treat the symptoms associated with AIDS, including Acylovir, Cotrimoxazole
or Fluconazole. According to the Department of Health's policy guidelines
issued in August 2000, it is government policy to treat such opportunistic
infections and to admit such patients to state hospitals in serious cases.
SOUTH AFRICAN DEPARTMENT OF HEALTH, RECOMMENDATIONS FOR THE
PREVENTION AND TREATMENT OF OPPORTUNISTIC AND HIV RELATED DISEASES

IN ADULTS 12-13, available at http://www.doh.gov.za/aids/docs/adult.html (last
visited Mar. 21, 2002). However, many individuals fail to gain access to such
prescribed treatment for of a variety of reasons. Individuals living with
H1V/AIDS needing treatment in state medical institutions should have access
to quality care. Care is often not available at many state hospitals due to a
lack of trained staff, facilities and leadership.
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available at such hospitals. Due to budget constraints, drugs run
out and there are then not always additional funds to provide
more drugs. Nevertheless, in principle, all HIV positive South
Africans have access to care once they fall prey to opportunistic
infections.
What people living with HIV/AIDS who cannot afford private
health care have no access to is potentially life saving antiretroviral drug therapy.96 Even people with some access to the
private health care facilities through medical aid and private
funds can sometimes not afford to pay for these drugs because
they are not covered by medical aid and because they are still too
expensive.97 At the moment, the government has no plans and has
apparently not taken any action that would progressively make
anti-retroviral therapy available to more and more HIV positive
individuals in either the private or public health sectors.
One of the biggest stumbling blocks to providing more people
with better access to appropriate treatment, other than lack of
political will, remains high drug prices. 98 Moreover, the single
biggest barrier to cheaper prices is the strict enforcement of
patents. 99 _Where patents are strictly enforced, drug companies are

96. SOUTH AFRICAN DEPARTMENT OF HEALTH, HIV/AIDS/STD STRATEGIC

PLAN
FOR
SOUTH
AFRICA
2000-2005,
91 2.2,
available at
http://www.doh.gov.za/aids/docs/aids-planOO-05.pdf (last visited Mar. 21,
2002).

97. When these drugs were first introduced, the cost for South Africans who
could afford it was around R4000 per month. The cost for such treatments is
presently between R600 and R1000 per month. Dianne Black, Cost of Living
with Aids: When Theory Gives Way to Experience, MAIL & GUARDIAN (Aug. 3,
(last
2001), at http://www.sn.apc.org/wmail/issues/010803/OTHER71.html
visited Mar. 18, 2002).
98. For a discussion of additional barriers, see Richard P. Rozek & Nicola
Tully, The TRIPS Agreement and Access to Health Care, 2 J. WORLD INTELL.
PROP. 813 (1999). The authors argue that "[i]n many instances, the prices of
pharmaceuticals are not the cause of access problems. If the patient does not
have access to a physician, or lacks accurate information, prices of
pharmaceuticals are irrelevant." Id. at 818. While the affordability of drugs is
clearly not the only barrier to effective treatment, what remains clear is that
for as long as drugs remain out of reach for most people with HIV/AIDS,
governments have little incentive to put systems in place to deal with efficient
distribution and strict compliance with often complicated drug-taking regimes.
Further, for as long as drugs remain inaccessible, the debate about health
system infrastructure remains purely academic. In addition, high drug prices
are the only obstacle in the way of access to treatment for many people with
HIV/AIDS in a country such as South Africa. One may also argue that any
comprehensive and adequate program to progressively provide access to
HIV/AIDS treatment and care programs will act as a catalyst to the
development of health infrastructure. This is an important point, but cannot
be discussed further in the limited space of this Article.
99. Brazil remains the clearest example of this point. See Tina Rosenberg,
Look at Brazil, N.Y. TIMES, Jan. 28, 2001, § 6 at 26 (discussing the correlation
between weaker patent protections and increased access to essential drugs).
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free to charge prices they wish.0 0° This, in turn, ensures that the
prices of life-saving drugs, including anti-retroviral drugs, remain
out of reach of most South Africans.
In 1997, the South African government took the first steps to
begin to address this problem. By adopting the Medicines and
Related Substances Control Amendment Act,_amendments were
made to the Medicines Act to allow for the introduction of three
important measures that will bring down the prices of drugs [and]
also anti-retroviral drugs.'Firstly, it allows for generic
substitution of off-patent medicines and medicines imported and
produced under compulsory licenses.
This means that
pharmacists are compelled by the Act to prescribe a cheaper
generic version of a medicine, if one exists, when presented with a
prescription by a patient.
Generic medicines are usually produced when the patent on a
drug has lapsed and generic substitution will therefore usually not
apply to patented drugs. As most anti-retroviral drugs are still
protected by patent, this provision will not have any great effect on
the cost of anti-retroviral drugs. °2 _ Secondly, the Act amends the
The pharmaceutical industry argues that patents are not the problem with
access to AIDS drugs in the developing world because the infrastructure is not
available and circumstances are too chaotic to make drug delivery realistic.
But this is a simplistic view, particularly in a country like South Africa where
the required infrastructure does exist in many places.
100. Meaningful reductions in prices can be achieved even where patents are
strictly enforced. For example, governments may seek agreements or obtain
voluntary licenses from drug companies subject to a royalty payment for
manufacturers to supply affordable medicines for the production, marketing
and sale of generic alternatives.
101. § 22F of Medicines and Related Substances Control Amendment Act
101 of 1965, available at http:/www.gov.za/acts/1997/a90-97.pdf (last visited
Mar. 21, 2002).
102. Id.; Treatment Action Campaign, An Explanation of the Medicines Act
and the Implications of the Court Victory, Q ONLINE, (Apr. 24 2001), available
at 2001http://www.q.co.za/2001/2001/0425-tacstatement.html
(last visited
Mar. 19, 2002). While many key anti-retroviral drugs used in the fight against

HIV/AIDS have had several years of patent protection, the patents are nearing
expiration for Pfizer's Diflucan (Fluconazole) and Glaxo SmithKline's Retrovir
(Zidovudine or AZT). According to the United States Food and Drug
Administration's (FDA) Orange Book, Pfizer's United States patent on
Diflucan expires on January 29, 2004.
Background Information on
Fluconazole (Diflucan), Consumer Project on Technology, available at
http://www.cptech.org/ip/health/fluconazole/info.html (last visited Mar. 19,
2002). Glaxo SmithKline's United States patent on Retrovir expires on
September 17, 2005. Background Information on Fourteen FDA Approved
HIVIAIDS Drugs, Consumer Project on Technology, available at
http://www.cptech.org/ip/health/aids/druginfo.html (last visited Mar. 19, 2002).
The online version of the FDA's Orange Book can be accessed at
http://www.fda.gov/cder/ob/ (last visited Mar. 23, 2002). Pfizer's South African
patent on Diflucan is said to expire at the end of 2002. Letter from the
Treatment Action Campaign, to William C. Steere, Chief Executive Officer,
Pfizer,
(June
20,
2000),
available
at
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Medicines Control Act to allow for the parallel importation of
patented medicines. 3 This allows the government to import
patented Medicine from another country where it is sold at a lower
price than in South Africa. Because pharmaceutical companies do
not charge the same price for identical drugs in different countries,
this section would allow the government to import drugs protected
by patent from cheaper countries, like Indian and Brazil, than
which the pharmaceutical company in South Africa would have
provided it to them for. Thirdly, the amendments provides for a
transparent medicine pricing system through the establishment of
This section requires pharmaceutical
a pricing committee.
companies to justify the prices they charge and empower the
pricing committee to make recommendations to the Minister of
Health on the introduction of a transparent pricing system.""
All three of these provisions were challenged by thirty-nine
pharmaceutical companies in the Transvaal Provincial Division of
the High Court towards the end of 2000 in The Pharmaceutical
Manufacturers' Association v. The President of the Republic of
0 _
The pharmaceutical companies challenged the
South Africa.0'
constitutionality of the three provisions of the Act set out above,
inter alia, on the premise that it infringed on the right to property
protected in section 25 of South Africa's Constitution. Under
severe public pressure in South Africa and the rest of the world,
the companies abandoned their case, and in effect agreed that the
government had a right to implement the provisions set out
above.' °
At the time of writing, the government has not yet issued
regulations to make these sections of the amendments operative
and has therefore not been in a position to utilize this Act to
import cheaper patented drugs from elsewhere or to regulate the
pricing of drugs. Neither has [the government] taken any other
tangible measures in any attempt to bring down the prices of antiretroviral or other life-saving drugs. It has not shown any interest
in issuing compulsory licenses to manufacture patented drugs to
make use of the relaxation of the TRIPS [Trade Related Aspects of

http://www.tac.org.za/Documents/Other/pfifinlt.html

(last visited Mar. 23,

2002).
103. Medicines and Related Substances Control Amendment Act § 15C.
104. Id. § 22G.
105. Pharmaceutical Mfr. Ass'n of S. Afr. v. President of the Republic of S.
Afr., 1999 (4) SA 788 (S. Afr.Transvaal Provincial Div.).
106. Id. The "climb down" on the pharmaceutical companies was arguably a
good tactical move because the amendments they challenged were not
particularly

threatening to their profits and interests,

including

the

amendment that permitted the parallel importing of cheaper drugs. What
pharmaceutical companies fear most is legislation that allows a state to issue
compulsory licenses that permit manufacturers to make patented drugs.
Rosenberg, supra note 36.
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Intellectual Property Rights] agreement thrashed out at Doha,
Qatar. The Ministerial meeting in Qatar decisively confirmed that
countries have a right to make exceptions to the TRIPS
agreement, including the issuing of compulsory licenses, if a
national emergency exists. A national emergency includes a
public health crisis, such as the one related to HIV/AIDS. °7
Despite this, the South African government has given no
indication that they would exploit this gap provided to them.
IV. THE CONSTITUTION, THE RIGHT OF ACCESS TO HEALTH CARE
AND HIV/AIDS TREATMENT IN SOUTH AFRICA
In order to get the government to change the way it is dealing
with HIV/AIDS in South Africa, civil society, especially the
Treatment Action Campaign, has been following a two-pronged
strategy.
On the one hand, they have been mobilizing
international support as well as political support inside South
Africa in order to put pressure on the government to take action on
the prevention and treatment of HIV/AIDS. On the other, it has
turned to the courts and has been using the provisions of the
Constitution, especially those relating to the right of access to
health care services, to embarrass the government into action.
Why the Constitution? The right of access to healthcare services
protected in section 27 of the Constitution is clearly justiciable. °8
107. See Agreement on Trade-Related Aspects of Intellectual Property
Rights, Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade
Organization, Annex 1C, art. 31, 33 I.L.M. 81 (1994) [hereinafter TRIPS

Agreement]; Ministerial Conference, Declarationon the TRIPS Agreement and
Public Health, WT/MIN(01)DEC/2, 4th Sess., WTO Doc. No. 01-5860 (Nov. 20,
2001) [hereinafter TRIPS Declaration] (reading the TRIPS Agreement and

TRIPS Declaration together means that a nation may grant compulsory
licenses for the current HIV/AIDS crisis). The TRIPS Declaration states that:
Each Member has the right to grant compulsory licenses and the
freedom to determine the grounds upon which such licenses are
granted.
Each Member has the right to determine what constitutes a
national emergency or other, circumstances of extreme urgency, it
being understood that public health crises, including those related

to HIV/AIDS, tuberculosis, malaria and other epidemics, can
represent a national emergency. Or other circumstances of extreme
urgency.
The effect of the provisions in the TRIPS Agreement that are
relevant to the exhaustion of intellectual property rights is to leave
each Member free to establish its own regime for such exhaustion

without challenge, subject to the MFN and national treatment
provisions of Articles 3 and 4.
TRIPS Declaration, supra, at art. 5.

108. In re Certification of the Constitution of the Republic of S. Mr., 1996 (4)
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The question is how this right may be enforced in a given case. In
a recent case, Grootboom v President of the Republic of South
Africa, the Constitutional Court spelled out how these rights,
including the right of access to health care services protected in
section 27 of the Constitution, can be enforced.- °9 It agreed that
these rights engender both the negative and positive-obligations
for the state and other relevant role players._110 In doing so, it
made extensive use of the work of the United Nations Committee
on Economic, Social and Cultural Rights, especially its General
Comments issued by the Committee.'
The court stated that, on a negative level, section 27 places
negative obligations on the state and other relevant role players to
desist from preventing or impairing the right of access to health
care services. 2 - Any action by the state that would take away
existing access to health care services or would make it more
difficult for an individual to gain access to existing health care
services would thus potentially result in an infringement of this
right. In the context of the provision of providing access to antiretroviral drugs for all people exposed to HIV or people living with

SA 744, 800 (CC).
109. South Africa v. Grootboom, 2000 (11) BCLR 1169 (CC), available at
2000 SACLR Lexis 6. See also Pierre de Vos, Pious Wishes or Directly
Enforceable Human Rights?: Social and Economic Rights in South Africa's
1996 Constitution, 1997 S.AFR. J. HUM. RTS. 67, 73 (discussing a general

exposition on the duties engendered by social and economic rights in South
Africa) [hereinafter de Vos, Pious Wishes].

110. Id. at 79, 83. According to section 8(2) of the South African Bill of
Rights, certain circumstances may bind natural and juristic persons. S. AFR.
CONST. (Constitution Act 108, 1996), ch. II (Bill of Rights), 8(2). Stephen
Ellmann has argued that section 27(1) of the South African Constitution's Bill
of Rights may bind pharmaceutical companies in the context of the South
African HIV/AIDS crisis. Stephen Ellmann, Post-Apartheid Constitutions:
Perspectives on South Africa's Basic Law 444-480 (Witwatersrand Univ. Press
et al eds., 2001). This is because most South Africans are denied access (in the
negative sense) to anti-retroviral drugs. The pharmaceutical companies'

actions could be unconstitutional if their "legitimate interests" do not justify
their continuous denial of access to anti-retroviral drugs. Id. at 461. Refusing
to reduce the cost of anti-retroviral drugs, could be unconstitutional if it is
feasible

for pharmaceutical

companies

to lower their prices

without

compromising their financial stability. Id. However, it is beyond this Article's
scope to explore the duties of private institutions and individuals to provide
access to healthcare services. See, e.g., de Vos, Pious Wishes, supra note 46, at

80 (discussing at length the South African Constitution's guarantee that
.every person [has] the right ...to housing, health care, sufficient food and
water, social security and the right to basic education ....).
111. See U.N. ESCOR, 5th Sess., Supp. 3, Nov.-Dec. 1990, U.N. Doc.

E/1991/23 (1990) (discussing the general nature and scope of the state parties
obligation in terms of a 2(1) of the Covenant on Economic, Social and Cultural

Rights).
112. In re Certification of the Constitution of the Republic of S. Afr., at 800
(CC); Grootboom, 2000 (11) BCLR, 34.
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HIV/AIDS, any action of the state to, say, prohibit doctors in either
the public or private health sector from dispensing a specific antiretroviral
drug would constitute a prima facie infringement of the
13
right."
On a positive level, this meant that section 27 of the
Constitution also places a positive obligation on the state and
other relevant actors to "protect, promote and fulfill" the right of
access to healthcare."4 At the very least, this means that the state
must take steps, including the enactment of legislation, to ensure
that individuals can acquire access to health care without
interference from private actors and institutions. It furthermore
means that the state has a duty to devise and implement,
progressively and within its available resources, a comprehensive
plan to ensure the full realization of the right of access to health
care for all. This plan cannot merely be aimed at providing
individuals with basic medicine, primary healthcare services and
with access to hospital care. '
What is required is a holistic approach aimed at providing all
South Africans with access to adequate, comprehensive health
care that will enable an individual to live a healthier and more
productive life." 6 This means that the state has a duty to foster
conditions to enable citizens to gain access to health care services
on an equitable basis. ' 7 What is required is for the state "to devise
a comprehensive and workable plan to meet its obligations" in
terms of section 27.118
Implicit in this approach, is the
understanding that the right of access to healthcare services does
not entitle any applicant to individual relief because the state's
duty is not immediately to provide each and every South African
with the best possible healthcare that money can buy, but to
devise and implement a comprehensive plan that will achieve this
goal over time." 9
113. Last year an NGO was evicted from a state hospital in Nelspruit
because they provided voluntary counseling, testing and anti-retroviral drugs
to rape survivors. Sizwe sama Yende, supra note 18. Pharmaceutical
companies arguably act unconstitutionally when they deny individuals access
to anti-retroviral drugs through their pricing policies. Smith, Hospitals
Participatingin the Programme,supra note 24.
114. S. AFR. CONST. (Constitution Act 108, 1996), ch. II (Bill of Rights),

7(2) (stating that the state "must respect, protect, promote and fulfill the
rights in the Bill of Rights.").

115. Grootboom, 2000 (11) BCLR, 9135. (stating that the right of access to
housing "requires more than brick and mortar").
116. To achieve this in the context of HIV/AIDS, individuals would need
primary health care services, information about HIV, voluntary testing and
counseling facilities, anti-retroviral drugs, etc.
117. Grootboom, 2000 (11) BCLR,
93. (stating that a program was not
reasonable if it "excluded a significant segment of society").
118. Id. 38.
119. Id. 9194-95.
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When devising and implementing this plan, the state must
take cognizance of the conditions and capabilities of people of all
economic levels of our society. 12 Those who could afford to pay for
health care should do so themselves, but where people have no
money to pay, the state has a duty to take steps to unlock the
system through legislation and other measures. What is required
is that the state must address the needs of those who can afford
healthcare and those who cannot. More importantly, the "poor are
particularly vulnerable and their needs require special
attention."1
The crux of any inquiry about whether the state has met its
obligations in terms of section 27(1) will depend on what
constitutes such appropriate steps. Steps will be appropriate if
they meet three key elements set out in section 27(2), namely (a)
whether they are reasonable legislative or other steps; (b) to
achieve the "progressive realisation of the right;" (c) within
available resources .22
The obligation on the state is therefore firstly to act
reasonably in pursuit of realizing the goal of providing accessible
and affordable health care services for people from all economic
spheres. To judge the reasonability of the steps taken it must be
determined whether
there is a comprehensive
policy,
encompassing all three tiers of government, to progressively
realize the right of access to healthcare.'2 _ Legislation in itself will
not be sufficient. What is required is for the state to act in order to
achieve the intended result according to comprehensive policies
and programs that are reasonable both in their conception and
implementation.U
To determine whether such measures are reasonable, it will
be necessary to consider health care problems in its social,
economic and historical context and to consider the capacity of
institutions responsible for implementing the program.
The
program must be "balanced and flexible" and a program "that
excludes a significant segment of society cannot be said to be
reasonable."12 _ More pertinently, those whose needs are the most
urgent and whose ability to enjoy all rights are most in peril, must
not be ignored by the measures aimed at achieving the realization
of the goal. Where measures, though statistically successful, fail
to respond to those most desperate, they may not pass the test of
reasonability. 26
This signals the inter-related and mutually

120.
121.
122.
123.
124.
125.
126.

Id. 35.
Id. 36.
Grootboom, 2000 (11) BCLR, $ 41.
Id.
Id. 42.
Id. %43.
Id. T 44.
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supporting nature of the right of access to health care services and
the right to equality and the overarching goal of striving for 'real'
equality and a respect for dignity. State action or inaction that
fails to take into account the structural inequalities in society;
action that fails to take into account the impact of that action or
inaction on the relevant groups who are most vulnerable and in
greater need of state assistance, such actions will inevitably
become difficult to be judged to be reasonable. As is the case in
equality jurisprudence, the impact of the acts or omissions must be
judged with reference to the very specific context in which the
complainants find themselves, including the calamity of the
HIV/AIDS crisis that South Africa faces.
The second requirement of progressive realization signals
that the right cannot be realized immediately. What is required is
that the state takes steps immediately to progressively facilitate
access to health care services. The state has a duty to move
expeditiously and effectively towards that goal. Any deliberate
retrogressive measures in that regard would also require the most
careful consideration and would need to be fully justified by
reference to the totality of the rights provided in the Bill of
Rights.127 It is imperative to understand that the requirement of
progressive realization of rights does not mean the state can sit
back and do nothing. It must take steps immediately, even if
those steps will not provide every South African with immediate
access to adequate, humane and effective health care.
To determine whether the state's action or inaction is
reasonable, one has to take into account the resources available to
actually realize the right in question. There always has to be a
balance between goal and means. The measures have to be
calculated to attain a goal expeditiously and effectively but the
availability of resources would always be an important factor in
determining what was reasonable in a particular case." Where
resources are clearly insufficient to attain any meaningful access
to certain forms of health care, a lack of action on the part of the
state may be found to be more reasonable than in cases where the
resource constraints are less severe. When considering resource
constraints, it may be kept in mind that resources here refer to
both the resources within the state and those available from the
international community through international cooperation and
assistance.
In the HIV/AIDS arena this would include any
assistance provided by the new global fund to combat HIV/AIDS or
other international assistance. 29
127. Grootboom, 2000 (11) BCLR,
128. Id. $ 46.

45.
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V. CONCLUSION

The state's inexplicable inertia in expanding access to
treatment and care for people living with HIV/AIDS is a major
stumbling block in the way of a realistic and humane HIV/AIDS
policy for South Africa. The only way to effectively challenge this
inaction is probably through a combination of political
mobilization and legal action.
Regarding the latter, the
constitutional provisions guaranteeing access to healthcare
services could play a major role in challenging the policies of the
government where they seem completely unreasonable or even
irrational. While NGOs like the Treatment Action Campaign have
had some success in this regard, there is still a very long way to
go.

AIDS AND INTERNATIONAL HUMAN
RIGHTS LAW
MARK E. WOJCIK*
Twenty years have passed since the U.S. Centers reported the
first clinical reports of AIDS for Disease Control. The disease has
touched every corner of the globe-it is our first global epidemic, a
true pandemic. Since 1981, more than sixty million people have
been infected with HIV. Twenty million of these persons have
died, three million in the last year alone. This is an average of
8,200 deaths a day. Of the three million persons who died in 2001,
an estimated 580,000 deaths were of children under the age of
fifteen-almost 1,600 deaths of children every day. Africa has
been hardest hit. An estimated 2.3 million Africans died of causes
related to AIDS in 2001.13 ° In many African countries, people are
dying at a younger age than they did ten years ago.'
The reality of these deaths is often lost on many in developed
countries where advanced pharmaceuticals are (or should be)
available to prolong the lives of persons infected by HIV. For
persons who have access to these "cocktail" drugs, HIV is a
http://www.un.org/ecosocdev/geninfo/afrec/voll5no/15nolpdf/15laidsl.pdf
(last visited Apr. 16, 2002). Fleshman reports that the Bill and Melinda Gates
Foundation and the drug company Merck fund the anti-retroviral program in
Botswana.
Associate Professor of Law, The John Marshall Law School,
Chicago.
This essay is adapted from a presentation given at the 2002 Annual Meeting

of the Association of American Law Schools. The author thanks Deans R.
Gilbert Johnston and John Corkery of The John Marshall Law School for their
support.
130. THE ECONOMIST, Dec. 22, 2001, at 6.
131. Terrorism Is Not the Only Scourge - It Is Also Time to Declare War on
Disease in Poor Countries, THE ECONOMIST, Dec. 22, 2001, at 10.
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manageable disease, or at least it is perceived as such by members
of the public and the politicians they elect. Death and its
consequences are forgotten in the new epidemic of complacencyone fueled by magazine advertisements that purport to show
handsome men with HIV climbing mountains or laughing with
friends. Other publications and cultural influences that appear to
glorify unsafe sexual practices reveal that we have learned
nothing from the deaths of our friends.
Most of the forty million persons living today with HIV face a
very different reality from that depicted in the magazine
advertisements. Most people simply lack access to the drugs
advertised in the magazines, although lawsuits in places as
widespread as Costa Rica, Israel, and South Africa attempt to
challenge that lack of access."'
New infections continue unabated. In the year 2001, an
estimated 3.4 million persons in Africa contracted HIV. 33 Around
the world an estimated five million persons were newly infected
with HIV. That is 13,000 to 14,000 new cases every day last year.
Women accounted for 1.8 million of those cases-almost 5,000
cases every day last year. And children under the age of fifteen
accounted for
an estimated 800,000 cases-almost 2,200 new cases
4
every day.1
The global response to this crisis is disappointing in many
aspects. But there has been some progress. In June, the United
Nations General Assembly held a Special Session on HIV during
which it promulgated highly optimistic goals to control the further
spread of HIV. That conference set a framework for national and
international accountability to fight AIDS. Governments pledged
to aggressively pursue the targets relating to HIV prevention and
care and agreed on specific strategies that must be developed by
the year 2003.
I believe that the specific goals are very ambitious. I would
be thrilled if they could be achieved, even partially. I welcome any
progress. But I am worried that many countries will fall short of
these national and international goals. For example, United
132. See, e.g., Ravi Nessman, Court Rules that South Africa Must Start
Providing Key AIDS Drug, HONOLULU ADVERTISER, Apr. 5, 2002, at A18

(reporting a ruling from the Constitutional Court upholding an order that the
government must make available to pregnant women with HIV the drug

nevirapine, which may reduce by fifty percent the chance of transmitting HIV
during labor).
133. The World This Year, THE ECONOMIST, Dec. 22, 2001, at 6.
134. Analysis and current figures are available at www.unaids.org, the

website of UNAIDS, the United Nations Programme Against AIDS. That
website also contains useful links to policy statements and background
materials for many of the international issues relating to the AIDS pandemic.
See also, e.g., Mark E. Wojcik et al., InternationalHuman Rights, 35 INT'L

LAw. 723, 725 (2001).
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Nations Secretary General Kofi Anan called for the establishment
of a new global fund of seven to ten billion dollars to prevent and
treat AIDS, tuberculosis, and malaria. 135 By the end of 2001,
however, the Global AIDS and Health Fund had received pledges
amounting to only 1.7 billion dollars. 3 6 Economic recession in the
United States and other nations make it unlikely that
governments or private corporations can fill this funding gap,
particularly as there is as yet no consensus that money targeted
for this fund will be an effective use of those funds. 37
I am worried that countries lack the political leadership to
meet the targets. In our own country, the national AIDS czar has
all but vanished from the public eye. And the goals of the United
Nations Global AIDS Conference-agreed to before the tragedies
of September 11, 2001-may be forgotten by the public and our
public leaders in favor of other concerns about anthrax and airline
safety.
I am also concerned about countries where progress on these
goals does not seem possible at all. The President of South Africa
continues to deny that HIV is a problem and that HIV is its cause.
This does tremendous harm to efforts there to combat the illness.
In other countries, discrimination against men who have sex with
men makes it impossible to provide public health information to
them. In Malaysia, a leading politician is appealing his sodomy
conviction and nine-year jail sentence. In Egypt, men charged
with moral crimes have been sentenced to long prison terms at
hard labor. And in Saudi Arabia, men accused
of having sex with
38
other men were publicly beheaded by sword.
Persons with HIV and persons at risk of HIV face an amazing
array of prejudice and discrimination in education, employment,
family law, travel and immigration, housing, medical services, and
even access to funeral and burial services. 13
These acts of
prejudice and discrimination should be seen for what they areviolations of human rights and of international human rights law.
Some violations are more serious than others. But all of them fall
within the framework of customary and conventional international
human rights law. This is often forgotten where concerns about
135. The Health of Nations - Will a New Report PersuadeRich Countries to
Spend Another $27 Billion a Year on Other People's Health?, THE ECONOMIST,

Dec. 22, 2001, at 83, 84.
136. Id.
137. For its part, the United Nations is optimistic about enticing a wide

range of donors to the Global AIDS and Health Fund. See, e.g., Global AIDS
Fund to Be Disbursed,38 U.N. CHRON. 77 (2001-2002).
138. Saudis Execute 3 Men for Sodomy, THE ADVOCATE [Baton Rouge, La.],
Jan. 2, 2002, at 2A; Katie Szymanski, U.S. Silent on Saudi Sodomy Execution,
BAY AREA REPORTER, Jan. 10, 2002, at 14.
139. See, e.g., Mark E. Wojcik, DiscriminationAfter Death, 53 OKLA. L. REV.

389 (2000).
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persons with HIV is viewed by an "us" versus "them" mentality-a
balancing of rights rather than a recognition that legitimate
concerns can be mutually accommodated to promote both human
rights and public health.
The traditional human rights instruments, including for
example, the Universal Declaration of Human Rights (UDHR),"4 °
the International Covenant on Civil and Political Rights
(ICCPR),41 and the International Covenant on Economic, Social,
140. G.A. Res. 217, U.N. GAOR, 3rd Sess., U.N. Doc. A/810 (1948), also
reprinted in BARRY E. CARTER & PHILLIP R. TRIMBLE, INTERNATIONAL LAW:
SELECTED

DOCUMENTS 381 (1995). Although the Universal Declaration on

Human Rights is not a treaty, nations "have endowed it with great legitimacy
through their actions, including its legal and political invocation at the
national and international levels." Jonathan M. Mann et. al., Health and
Human Rights in HEALTH AND HUMAN RIGHTS: A READER 9 (Jonathan M.
Mann et al., eds. 1999). The Declaration provides in article 1 that "[aill
human beings are born free and equal in dignity and rights" and in article 2
that "[e]veryone is entitled to all the rights and freedoms set forth in this
declaration, without discrimination of any kind, such as race, colour, sex,
language, political or other opinion, national or social origin, property, birth or
other status." Language such as "everyone," "without discrimination of any
kind," and "other status" makes the document broad enough to cover persons
affected by HIV. Similarly broad language is found in article 3, which
recognizes that "[elveryone has the right to life, liberty and the security of the
person," and article 7, which provides in part that "[aill are equal before the
law and entitled without any discrimination to equal protection of the law."
Article 12 recognizes a right of privacy, article 16 recognizes a right to marry,
and article 23 recognizes a right to work. These protections are important to
recall as nations from time to time have attempted to restrict the right of
persons with HIV to marry or to work. Article 22 provides that "[elveryone, as
a member of society, has the right to social security and is entitled to
realization, through national effort and international cooperation and in
accordance with the organization and resources of each State, of the economic,
social and cultural rights indispensable for his dignity and the free
development of his personality." And article 25(1) recognizes that "[elveryone
has the right to a standard of living adequate for the health and well-being of
himself and of his family, including food, clothing, housing and medical care
and necessary social services, and the right to security in the event of
unemployment, sickness, disability, widowhood, old age or other lack of
livelihood in circumstances beyond his control." Many of these rights
obviously apply to persons affected by HIV.
141. 999 U.N.T.S. 171 (1966), also reprinted in BARRY E. CARTER & PHILLIP
R. TRIMBLE, INTERNATIONAL LAW: SELECTED DOCUMENTS 387 (1995). Among
the protections that might apply to persons with HIV are the inherent right to
life in article 6(1), freedom from inhuman or degrading treatment or
punishment in article 7, the prohibition on non-consensual medical or
scientific experimentation also found in article 7, the right to liberty and
security of the person under article 9, and in article 10, the right for persons
who are deprived of their liberty to "be treated with humanity and with
respect for the inherent dignity of the human person." Article 16 recognizes
that "[elveryone shall have the right to recognition everywhere as a person
before the law"; and article 17 recognizes that "[elveryone has the right to the
protection of the law against ... interference or attacks" on the individual's
right to privacy. The right to marry is recognized in article 23, and article 24
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and Cultural Rights (ICESCR),"' apply to persons affected by HIV.
In these major human rights declarations and conventions the full
spectrum of rights apply to all persons, including persons affected
by HIV. Rights such as the right to life, the right to privacy, and
the right of the individual to be treated with respect and dignity
all apply to persons living with HIV.
Other applicable
international human rights instruments include the International
Covenant on the Elimination of All Forms of Racial Discrimination
(CERD),"' the Convention on the Elimination of All Forms of
Discrimination Against Women (CEDAW), ' the Convention
T

provides special recognition for the protection of children. The United States
has ratified the ICCPR, albeit with a reservation that articles 1 through 27 are
not self-executing and therefore cannot be independently used in domestic
courts as a source of legal obligation. See 138 Cong. Rec. S4781 (1991), also
reprinted in BARRY E. CARTER & PHILLIP R. TRIMBLE, INTERNATIONAL LAW:
SELECTED DOCUMENTS 404 (1995).
142. 99 U.N.T.S. 3 (1966), also reprinted in BARRY E. CARTER & PHILLIP R.
TRIMBLE, INTERNATIONAL LAW: SELECTED DOCUMENTS 410 (1995).
The
Covenant provides in article 2(2) that the rights it recognizes are to be
exercised "without discrimination of any kind as to race, colour, sex, language,
religion, political or other opinion, national or social origin, property, birth, or
other status." This language is broad and includes non-discrimination based
on a person's HIV status. The rights recognized in the convention are the
right to work in article 6(1), the right to safe and healthy working conditions
in article 7(b), and the right to social security, including social insurance, in
article 9. Article 10(2) and 10(3) recognizes that special protection should be
given to mothers and to children and young persons. And Article 12(1)
provides that parties to the convention "recognize the right of everyone to the
enjoyment of the highest attainable standard of physical and mental health."
Achievement of this right to health requires the parties to take steps
necessary for "the prevention, treatment and control of epidemic, endemic,
occupational and other diseases."
143. 660 U.N.T.S. 195 (1966), reprinted in BARRY E. CARTER & PHILLIP R.
TRIMBLE, INTERNATIONAL LAW: SELECTED DOCUMENTS 423 (1995). Among its
many protections, CERD recognizes in article 5 "[t]he right to housing" and
'[the right to public health, medical care, social security and social services."
144. 1249 U.N.T.S. 13 (1979), reprinted in 19 I.L.M. 33 (1980), also reprinted
in BARRY E. CARTER & PHILLIP R. TRIMBLE, INTERNATIONAL LAW: SELECTED
DOCUMENTS 432 (1995).
CEDAW is particularly important in the fight
against AIDS because of the increased vulnerability of women. It contains a
number of broad general protections, such as article 3 which requires states to
"take in all fields ...

all appropriate

measures ...

to ensure the full

development and advancement of women, for the purpose of guaranteeing
them the exercise and enjoyment of human rights and fundamental freedoms
on a basis of equality with men." In addition to the broad general rights
identified in the convention, article 10(h) of CEDAW identifies "[access to
specific educational information to help to ensure the health and well-being of
families, including information and advice on family planning." Similarly,
article ll(1)(f) identifies "[tihe right to protection of health" and article 12(1)
requires states to "take all appropriate measures to eliminate discrimination
against women in the field of health care in order to ensure, on a basis of
equality of men and women, access to health care services, including those
related to family planning." Article 14(2)(b) identifies the right of "access to
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Against Torture and Other Cruel, Inhuman or Degrading
Treatment or Punishment, 4 ' and the Convention on the Rights of
the Child

46

and its Protocol

on Child Prostitution. 147

Many

regional agreements and regional human rights instruments also
relate to the discrimination faced by persons with HIV, including
instruments such as the American Declaration on the Rights and
Duties of Man," the American Convention on Human Rights, 49
adequate health care facilities, including information, counseling and services
in family planning."
145. G.A. Res. 39/46, U.N. GAOR, 39th Sess., Supp. No. 15, at 197, U.N. Doc.
No. AIRES/39/708 (1984), reprinted in 23 I.L.M. 1027 (1984), as modified 24
I.L.M. 535 (1985), also reprinted in BARRY E. CARTER & PHILLIP R. TRIMBLE,
INTERNATIONAL LAW: SELECTED DOCUMENTS 444 (1995). Inclusion of the
Torture Convention in a list of documents relating to the rights of persons
with HIV may be surprising until one considers the Convention's definition of
torture in article 1(1), which defines "torture" to include "any act by which
severe pain or suffering, whether physical or mental, is intentionally inflicted
on a person for such purposes as... punishing him for an act he or a third
person has committed or is suspected of having committed .... or for any
reason based on discrimination of any kind .... " The definition requires that
the acts alleged must be "inflicted by or at the instigation of or with the
consent or acquiescence of a public official or other person acting in an official
capacity." Id. at art. 1(1). The definition of torture also excludes "pain or
suffering arising only from, inherent in or incidental to lawful sanctions." Id.
146. 28 I.L.M. 1448 (1989), also reprinted in part in BARRY E. CARTER. &
PHILLIP R. TRIMBLE, INTERNATIONAL LAW: SELECTED DOCUMENTS 455 (1995).

The treaty has been ratified by every nation in the world except Somalia
(which has no functioning central government) and the United States. It
requires in Article 3(2) that nations "undertake to ensure the child such
protection and care as is necessary for his or her well-being" and in Article
19(1) that nations "take all appropriate legislative, administrative, social and
educational measures to protect the child from all forms of physical or mental
violence, injury or abuse, neglect or negligent treatment, maltreatment or
exploitation, including sexual abuse, while in the case of parent(s), legal
guardian(s) or any other person who has the care of the child .... "
147. Optional Protocol to the Convention on the Rights of the Child on the
Sale of Children, Child Prostitution and Child Pornography, G.A. Res. 54/263,
U.N. GAOR, 54th Sess., Agenda Item 116(a), U.N. Doc. No. A/RES/54-263
(2000), reprinted in 8 INT'L HUM. RTS. REP. 293 (2001). For a discussion of the
history and application of this protocol, see Mark E. Wojcik, et. al.,
InternationalHuman Rights, 35 INT'L LAW. 723, 726-28 (2001).
148. O.A.S. Res. XXX, O.A.S. Off. Rec. OEA/Ser. L/VJI.4 Rev. (1965), also
reprinted in BURNS H. WESTON, ET. AL., SUPPLEMENT OF BASIC DOCUMENTS
TO INTERNATIONAL LAw AND WORLD ORDER 368 (1997) [hereinafter O.A.S Res.

XXXI. See also Mark E. Wojcik, Using InternationalHuman Rights Law to
Advance Queer Rights: A Case Study for the American Declaration on the
Rights and Duties of Man, 55 OHIO ST. L.J. 649 (1994).
The
American Declaration of the Rights and Duties of Man was agreed upon before
the Universal Declaration of Human Rights. Rights recognized in the
American Declaration include the recognition in article 11 that "[elvery person
has the right to the preservation of his health through sanitary and social
measures relating to food, clothing, housing and medical care, to the extent
permitted by public and community resources." O.A.S. Res. XXX, supra.
149. 9 I.L.M. 673 (1970), also reprinted in BARRY E. CARTER & PHILLIP R.
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the Additional Protocol to the American Convention on Human
Rights in the Area of Economic, Social, and Cultural Rights,"' the
European Convention for the Protection of Human Rights and
Fundamental Freedoms and its protocols, 5 ' and the African
(Banjul) Charter on Human and Peoples' Rights. 5 2 There are, of

TRIMBLE, INTERNATIONAL LAW: SELECTED DOCUMENTS

488 (1995).

Article

1(1) of the Convention obligates states to "ensure to all persons subject to their
jurisdiction the free and full exercise" of rights and freedoms recognized in the
Convention. Those rights include "the right to have his physical, mental, and
moral integrity respected" under article 5(1); "the right to personal liberty and
security" under article 7(1); "the right to have his honor respected and his
dignity recognized" under article 11(1); the right to privacy under article 11(2);

and the right "without discrimination, to equal protection of the law" under
article 24. The Convention also confirms in article 32 that "[elvery person has
responsibilities to his family, his community, and mankind" and that "[tihe

rights of each person are limited by the rights of others, by the security of all,
and by the just demands of the general welfare, in a democratic society."
While this last language might be seen as justifying discrimination against
persons with HIV, it should be read in support of the idea that the key to
promoting public health is the protection of individual human rights.
150. 28 I.L.M. 156 (1989), also reprinted in BURNS H. WESTON, ET. AL.,
SUPPLEMENT OF BASIC DOCUMENTS TO INTERNATIONAL

LAW AND WORLD

ORDER 535 (1997). Among protections recognized in this document are the
obligation of non-discrimination in article 3, the right to work in article 6, the
right to social security in article 9, and in article 10(1), "the right to health,
understood to mean the enjoyment of the highest level of physical, mental and
social well-being." The parties agree in article 10(2) to "recognize health as a
public good," to adopt measures that provide education "on the prevention and
treatment of health problems," and to satisfy "the health needs of the highest
risk groups and of those whose poverty makes them the most vulnerable."
151. 312 U.N.T.S. 221 (1950), also reprinted as amended by protocols in
BARRY E. CARTER & PHILLIP R. TRIMBLE, INTERNATIONAL LAW: SELECTED

DOCUMENTS 464 (1995). Article 8 provides a right of privacy that may not be
interfered with except "for the protection of health or morals, or for the
protection of the rights and freedoms of others." A similar caveat accompanies
the right to freedom of expression in article 10. Under article 14, other rights
in the Convention, including the right to marry in article 12, are to "be secured
without discrimination on any ground such as sex, race, colour, language,
religion, political or other opinion, national or social origin, association with a
national minority, property, birth, or other status." The "other 'status"
language is broad enough to include a person's HIV status as a basis for nondiscrimination.
152. 21 I.L.M. 58 (1981), also reprinted in BARRY E. CARTER & PHILLIP R.
TRIMBLE, INTERNATIONAL LAW: SELECTED DOCUMENTS 509 (1995). Article 2,

for example, provides that "[elvery individual shall be entitled to the
enjoyment of the rights and freedoms recognized and guaranteed in the
present Charter without distinction of any kind such as race, ethnic group,
color, sex, language, religion, political or any other opinion, national and social
origin, fortune, birth or other status." Words such as "every individual,"
"without distinction," and "other status" are broad designations that include
persons affected by HIV. Similar phrases can be found elsewhere in the
document. Article 3(1), for example, provides that "[e]very individual shall be
equal before the law." Article 4 provides in part that "[elvery human being
shall be entitled to respect for his life and the integrity of his person." And
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course, many other conventions and instruments that might be
cited, including ones that specifically identify the problem of HIV
and AIDS.
Although there is a large number of documents that can be
invoked when creating protections for persons affected by HIV, the
international human rights framework is not always seen :as
coming into play because the instruments do not expressly
mention AIDS or HIV. I recall an incident in 1993 in the week
when the final declaration of the World Conference on Human
Rights had been issued in Vienna."'3 In those days we did not have
instant Internet access to such documents. I asked a colleague
who just read a copy of the Final Declaration before I did if there
was anything in there about protecting the human rights of
persons with AIDS. He said there was "nothing in it relating to
AIDS." But when I looked at the document, I saw throughout that
document an array of general and specific human rights
guarantees that could be applied to persons with AIDS, such as
"the rights of everyone to a standard of living adequate for their
health and well-being, including food and medical care, housing
and the necessary social services,"' or the call for effective
measures against child prostitution and other forms of sexual
abuse, 5 ' or the recognition that "[tihe speedy and comprehensive
elimination of all forms of racism and racial discrimination,
xenophobia and related intolerance is a priority task for the
international community""' and that "[r] espect for human rights
and for fundamental freedoms without distinction of any kind is a
fundamental rule of international human rights law."'57
I admit, of course, that there was no explicit mention of HIV or
AIDS in the final document itself, but I deny that there is "nothing
in it relating to AIDS." Therein lies the continuing challenge for
international human rights law (and national human rights laws).
We must identify the human rights norms that apply to persons
with HIV, and we must show that protecting those norms is not
article 5 provides that '[elvery individual shall have the right to the respect of
the dignity inherent in a human being and to the recognition of his legal
status." The Charter also guarantees the right to information about health in
article 9, which provides that '[elvery individual shall have the right to receive
information." And article 16 provides first that "[elvery individual shall have
the right to enjoy the best attainable state of physical and mental health," and
second that nations who are parties to the Charter 'shall take the necessary
measures to protect the health of their people and to ensure that they receive
medical attention when they are sick."
153. Vienna Declaration and Programme of Action, 32 I.L.M. 1661 (1993),
also reprinted in BURNS H.

WESTON, ET. AL., SUPPLEMENT OF
DOCUMENTS TO INTERNATIONAL LAW AND WORLD ORDER 625 (1997).

154. Id. at art. 31.
155. Id. at art. 48.
156. Id. at art. 15.
157. Id.
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only a laudable goal in itself, but necessary to protect and promote
public health in general.
Adopting references
to international
human
rights
instruments in our scholarship and teaching on AIDS will have
many benefits. First, acts of prejudice and discrimination against
persons affected by HIV will be seen as infringements or violations
of human rights. These are not violations that should simply be
ignored. Remedies should be pursued in national courts and
before international tribunals.
Second, our scholarship and
advocacy will support persons in this country who are affected by
HIV or who might be at risk of becoming infected with HIV. The
current levels of new infection are unacceptable. Our scholarship
and advocacy will also help persons in other countries. It has long
been known that AIDS cannot be cured in any country until it is
cured in all countries. We need to strengthen the international
law framework so that it can be used to help individuals and
organizations in other nations. We also need to learn from their
experiences. Many legal advances for persons living with HIV are
entirely unknown in the United States. While we have much to
offer others, we also have much to learn. Finally, we must
remember to put people back into the equation. When we say that
this disease has affected sixty million people over twenty years, it
obscures the fact that each of those cases is an individual story.
The process of identifying various human rights norms that apply
to persons living with HIV is only the first stage, however. The
second stage after identification of human rights norms is to
provide for enforcement of those norms. This is an issue not only
for persons affected by HIV, but also for all aspects of
international human rights laws. Norms may be recognized as
unenforceable aspirations rather than legal rights.
The
international human rights norms must develop into rights that
are enforceable in local, national, and international tribunals.
They must be enforceable in common law and civil law systems.
We have seen already some evidence of increased enforcement of
human rights norms, but enforcement is still often more of an
exceptions rather than a rule.
The third stage, after identification of norms and providing
opportunities for their enforcement, is to provide remedies for
those whose rights have been violated. As Professor John Van
Dyke of the University of Hawaii recently noted, "[t]he right to
obtain financial compensation for a human rights abuse and to
have the perpetrator of such an abuse prosecuted and punished is
itself a fundamental human right that cannot be taken from a
victim or waived by a government."15 Remedies are important not

158. John M. Van Dyke, The Fundamental Human Right to Prosecution and
Compensation, 29 Denver J. Int'l L. & Pol'y 77, 77 (2001).
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only for violations of civil and political rights, but also for
violations of economic and social rights, to the extent that national
and international resources are available.
The fourth and final stage is to prevent violations of rights.
Avoiding a violation of human rights in the first place is more
important than providing an opportunity for redress.
We are still to a large extent only in the first stage of this process.
That there is more work to be done does not diminish the
importance of the work being done now. But we see that we
cannot become complacent or despondent. Twenty years again
from now we will still be looking at AIDS and the human rights of
persons affected by HIV. We may not then have arrived at full
implementation of the fourth stage of preventing violations, but we
will hopefully have reached it in many cases. Let us see how close
we can come to fully achieving that goal.

